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Introduction
In the initial invasive phase, cancer cells migrate through the 
basement membrane and through different types of stromal 
ECM. These 3D structures display diverse physicochemical 
properties that, while providing a substrate for adhesion and 
traction, also impose different degrees of mechanical resis-
tance (Friedl and Alexander, 2011). Cancer cells confront 
these diverse migratory environments by adopting flexible in-
vasive strategies (Friedl and Wolf, 2010). In one such strategy, 
referred to as “mesenchymal motility,” invasion is achieved 
by coupling polarized actin-based protrusions with spatially 
restricted pericellular proteolytic activity in both migrating cells 
and reactive stromal cells (Egeblad et al., 2010; Kessenbrock 
et al., 2010). Invasion can also be achieved, however, in a pro-
tease-independent fashion (amoeboid motility; Madsen and 
Sahai, 2010). Although the physiological relevance of amoe-
boid motility has been questioned (Sabeh et al., 2009), it is 
likely that both proteolytic- and nonproteolytic modes of in-
vasion exist and cooperate during migration of cancer cells 
(Wolf et al., 2003). The resulting migration “plasticity” is thought 
to contribute to the diverse array of cancer invasion routes 
and programs, tumor heterogeneity, and, ultimately, meta-
static dissemination.
Podosomes and invadopodia, collectively defined as inva-
dosomes (Linder et al., 2011), are actin-rich, adhesive protrusions 
The mechanisms by which tumor cells metastasize and the role of endocytic proteins in this process are not well understood. We report that overexpression 
of the GTPase RAB5A, a master regulator of endocytosis, 
is predictive of aggressive behavior and metastatic ability 
in human breast cancers. RAB5A is necessary and sufficient 
to promote local invasion and distant dissemination of vari-
ous mammary and nonmammary tumor cell lines, and 
this prometastatic behavior is associated with increased 
intratumoral cell motility. Specifically, RAB5A is neces-
sary for the formation of invadosomes, membrane protru-
sions specialized in extracellular matrix (ECM) degradation. 
RAB5A promotes RAB4- and RABENOSYN-5–dependent 
endo/exocytic cycles (EECs) of critical cargos (membrane- 
type 1 matrix metalloprotease [MT1-MMP] and 3 integrin) 
required for invadosome formation in response to motogenic 
stimuli. This trafficking circuitry is necessary for spatially 
localized hepatocyte growth factor (HGF)/MET signaling 
that drives invasive, proteolysis-dependent chemotaxis 
in vitro and for conversion of ductal carcinoma in situ to 
invasive ductal carcinoma in vivo. Thus, RAB5A/RAB4 EECs 
promote tumor dissemination by controlling a proteolytic, 
mesenchymal invasive program.
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Figure 1.  RAB5A predicts poor clinical outcome in breast cancer patients and its expression is elevated in breast cancer lymph node metastases. (A–D) 
Kaplan–Meier plots for breast cancer patients stratified by RAB5A expression for the following groups of patients: (A) all 980 patients; (B) 695 patients 
with lymph node negative (N0) breast tumors; (C) 528 patients with lymph node–negative and ER-positive (N0 ER+) breast tumors; (D) 166 patients with 
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lymph node–negative, ER-positive, and Grade 2 (N0 ER+ G2) breast tumors. High RAB5A, >75th percentile; low RAB5A, ≤75th percentile. Y axes = the 
probability of local and distant relapse free survival (DFS). X axes = years of follow up. P-values are from a log-rank test. (E) RAB5A prognostic significance 
is independent from Ki67, and its expression is not associated with a proliferation signature. (E, left) Multivariate analysis with a Cox proportional hazard 
model on prognosis of patients with breast cancer. The RAB5A and Ki67 genes were used as covariates. High RAB5A or Ki67 expression levels, >75th 
percentile of the normalize expression distribution. Low RAB5A or Ki67 expression levels, ≤75th percentile. HR, hazard ratio by Cox model. 95% CI, 95% 
confidence intervals of HR. P-value, likelihood ratio 2 test on the null hypothesis that the parameter estimate for the RAB5A high/low, or Ki67 high/low, 
covariate is zero. (E, right) Gene set enrichment analysis (GSEA) analysis of a known proliferation signature (Ben-Porath et al., 2008) among genes ranked 
by signal-to-noise metric based on their correlation with Ki67 high/low or RAB5A high/low. FDR, false discovery rate based on 1,000 random permuta-
tions of class labels. (F) IHC staining of RAB5 on FFPE samples of a human primary infiltrating breast tumor (PT) and matched nodal metastasis (NM). 
N, normal duct; L, normal negative lymphocytes. Boxed regions are enlarged below. Bar, 500 µm. (G) Percentage of low and high RAB5A-expressing 
primary tumors and metastases. Normal breast tissue scores always range between 0 and 1. **, P < 0.000271 (2 test).
 
that degrade the ECM via the directed release of proteases 
(Tarone et al., 1985; Linder et al., 2011). The delivery of the 
membrane-type 1 matrix metalloprotease (MT1-MMP) to inva-
dosomes is critical for their formation and functionality (Hotary 
et al., 2003, 2006; Itoh and Seiki, 2006). MT1-MMP deliv-
ery to invadosomes can be achieved by its polarized secre-
tion in response to the activation of cell-adhesion receptors 
(Poincloux et al., 2009), through recycling from late endo-
somal compartments (Steffen et al., 2008; Yu et al., 2012; 
Monteiro et al., 2013), and by exosome release (Hoshino 
et al., 2013).
Some motogenic growth factors, such as EGF and hepato-
cyte growth factor (HGF), induce invadosomes in a transient 
and polarized fashion within minutes of stimulation (Yamaguchi 
et al., 2005; DesMarais et al., 2009; Frittoli et al., 2011). Under 
these conditions, the cell must interpret the signal in a limited 
time frame and simultaneously enact several spatially restricted 
programs leading to actin polymerization, extension of migra-
tory protrusions, and delivery of adhesion molecules and pro-
teases, first and foremost MT1-MMP. It seems reasonable to 
postulate the existence of a master regulator that orchestrates 
this sequence of events.
RAB5, a GTPase pivotal in endocytosis (Zerial and 
McBride, 2001; Zeigerer et al., 2012), is a fitting candidate for 
this role. We previously demonstrated that RAB5-dependent 
endocytic/exocytic cycles (EECs) of the small GTPase RAC1 
are sufficient to promote: (1) the spatial restriction of RAC1 
signaling, leading to the formation of polarized migratory pro-
trusions; (2) elongated cell migration and increased cell veloc-
ity; (3) an amoeboid-to-mesenchymal (AMT) switch in the 
mode of migration; and (4) the acquisition of invasive potential 
by different tumor cell types (Palamidessi et al., 2008). Here, 
we report that elevated expression of RAB5A, one of three 
functionally redundant RAB5 genes, is predictive of increased 
local and distant relapse in early stage estrogen receptor–positive 
(ER+), lymph node–negative (N0) breast cancer patients. RAB5A 
expression is significantly elevated in lymph node metastases 
with respect to matched human primary breast tumors. At the 
molecular level, RAB5A promotes RAB4-dependent fast recy-
cling of 3 integrin and MT1-MMP, leading to invadosome 
formation, degradation, and remodeling of the ECM. These pro-
cesses are, in turn, crucial for local tumor invasion and dis-
semination to distant organs. We propose that a RAB5A/RAB4 
recycling route is central in promoting proteolytic/mesenchymal 
invasive programs in human breast cancer.
Results
RAB5A expression is predictive of clinical 
outcome in breast cancer patients
RAB5 expression is sufficient to promote a mesenchymal mode 
of cell invasion (Palamidessi et al., 2008). Individual ablation 
of the three human RAB5 genes (RAB5A/B/C) has also been re-
ported to impair invasion and dissemination of different types 
of cancer cells (Yu et al., 1999; Torres et al., 2010; Torres and 
Stupack, 2011; Liu et al., 2011; Onodera et al., 2012; Mendoza 
et al., 2013; Diaz et al., 2014). However, a recent report indi-
cates that in normal macrophages RAB5A is dispensable for 
matrix degradation (Wiesner et al., 2013). We thus investigated 
whether RAB5 could be directly linked to naturally occurring 
human tumors and to metastasis.
We initially meta-analyzed five published human breast 
tumor gene expression datasets containing 980 primary breast 
cancers. This analysis revealed that overexpression of RAB5A, 
but not RAB5B or RAB5C (not depicted), correlates with poor 
prognosis (P = 0.031; Fig. 1 A). The prognostic power of RAB5A 
became progressively more significant in the following sub-
groups of patients: lymph node negative (N0; P = 0.01); N0 and 
ER+ (P = 0.003); and grade 2 (G2), N0, ER+ (P = 0.0004) breast 
tumor patients (Fig. 1, B–D). RAB5A prognostic significance 
was independent from the proliferation marker Ki67 as assessed 
in multivariate COX analysis (Fig. 1 E). Additionally, RAB5A 
levels do not co-vary with the signature associated with prolif-
eration as determined by gene set enrichment analysis (GSEA; 
Fig. 1 E).
Next, we examined the expression of RAB5A in a panel 
of normal human mammary gland tissues (N), primary human 
breast cancers (T), and their matched lymph node metastases 
(NM; n = 5, T = 35, M = 35). Immunohistochemical (IHC) 
analysis revealed that RAB5A was expressed at low levels in 
normal mammary epithelial, whereas in tumor and lymph node 
metastasis, its expression varied from barely detectable to highly 
expressed (Fig. 1 F). Importantly, RAB5A expression was sig-
nificantly higher in matched lymph node metastases, with re-
spect to their primary tumors (Fig. 1 G, P < 0.000271 2 test.). 
The up-regulation of RAB5A levels between each patient’s 
primary tumor and node metastasis is also highly significant 
when calculated with the Wilcoxon signed-rank test (P = 0.0055). 
Thus, RAB5 overexpression is an event that is selected for dur-
ing breast cancer progression, possibly because it confers a mi-
gratory advantage to tumor cells.
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Figure 2. RAB5A is required for tumor dissemination and for the conversion from DCIS to infiltrating mammary carcinoma. (A and B) Doxycycline-inducible 
RAB5AS34N- and control MDA-MB-231 cells were injected into the mammary fat pads of NSG mice. After 3 wk, mice were fed with doxycycline. 
Metastases were analyzed 4 wk after removal of primary tumor. (A) Ipsilateral metastasis (arrowhead) of control or RAB5AS34N-MDA-MB-231 tumors. 
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(A, right) Quantification (mean ± SEM [error bars]; n = 10 mice/group) of the number and size of disseminated tumors. (B) H&E of control and 
RAB5AS34N-MDA-MB-231 lung tissue sections (left). The size of metastatic nodules in lungs is the mean tumor area/lung area ± SEM (error bars; n = 9 
mice/group repeated in three independent experiments). (C) Mixtures of CFSE-labeled (green) scramble-transfected control (Ctr) and eFluor 670–labeled 
(red) RAB5A,B,C-depleted MDA-MB-231 cells (0.5 × 106 each) were coinjected into the tail vein of NSG mice. (C, left) Images of lung tissue. (C, middle) 
The number (mean ± SEM [error bars]; n = 10) of labeled control and RAB5A,B,C-depleted cells/field of lung tissue at the indicated times. **, P < 0.005. 
(C, right) Efficacy of RAB5 gene silencing by QRT-PCR. **, P < 0.005. (D) Doxycycline-inducible RAB5AS34N- and control-MCF10.DCIS.com cells were 
injected subcutaneously into NSG mice. After 4 d, mice were fed with doxycycline. (D, left) IHC analyses of control (Ctr) and RAB5AS34N-MCF10.DCIS.
com xenografts performed at 1 and 3 wk after doxycycline treatment. Representative images from three independent experiments are shown (n = 5 
mice/experimental condition). (D, right) mRNA level of RAB5AS34N expression in control (Ctr) and RAB5AS34N tumors. Error bars indicate SEM. **, P < 
0.005. (E) Control (Ctr) and RAB5A-MCF10.DCIS.com cells (5 × 105 each) were labeled with eFluor 670 and injected into NSG mice tail vein. 
(E, left) Images of lung tissue. (E, middle) The number (mean ± SEM [error bars]; n = 10) of labeled control and RAB5A-MCF10.DCIS.com cells per field at 
the indicated times. **, P < 0.005. (E, right) RAB5A expression by immunoblotting. Bars: (B) 2 µm; (C) 80 µm; (D) 100 µm; (E) 80 µm.
 
RAB5A is required for local and distant 
dissemination of breast cancer in vivo
We next established relevant cell model systems to study the 
involvement of RAB5A in local invasiveness and distant meta-
static dissemination. We chose the triple-negative breast cancer 
MDA-MB-231 and MCF10.DCIS.com cell lines. The former 
cells are invasive, disseminate to distant organs (Kang et al., 
2003), and display relatively elevated levels of RAB5 expres-
sion when compared with a panel of breast cancer cell lines 
(Fig. S1 A). In contrast, MCF10.DCIS.com cells recapitulate 
features of comedo-type ductal carcinoma in situ (DCIS), upon 
injection into immunodeficient mice (Miller et al., 2000). Be-
cause the three RAB5 genes are functionally redundant (Zeigerer 
et al., 2012) and essential for mitotic progression (Capalbo 
et al., 2011; Serio et al., 2011), we generated stable MDA-MB- 
231 and MCF10.DCIS.com cell lines that express a dominant-
negative RAB5A (RAB5AS34N) isoform in a doxycycline-
inducible fashion.
We xenografted RAB5AS34N and control MDA-MB-231 
cells into mammary fat pads of immunocompromised mice. 
After 3 wk, mice were fed with a doxycycline to induce the 
expression of the transgene, which was detected by immuno-
blotting (Fig. S1 B). We then analyzed local ipsilateral metasta-
sis (Fig. 2 A) and lung metastases after removal of the primary 
tumor (Fig. 2 B). The sizes of control and RAB5AS34N- 
expressing primary tumors were indistinguishable (Fig. S1 B). 
Conversely, there was a significant decrease in both the number 
and size of local and distant metastatic outgrowths in mice in-
jected with RAB5AS34N-MDA-MB-231 cells compared with 
mice injected with control cells (Fig. 2, A and B).
We also investigated the effects of simultaneously silenc-
ing the three RAB5 isoforms using siRNAs on the ability of 
MDA-MB-231 cells to disseminate in vivo. RAB5-depleted and 
control MDA-MB-231 cells were labeled with different fluor-
escent vital dyes, co-injected in equal numbers into the tail vein 
of immunocompromised mice, and then monitored for their 
ability to colonize the host lung. After 2 h, control and RAB5- 
depleted cells were present in the lung at a ratio of 1:1. How-
ever, at 24 and 96 h, the ratio of control to RAB5-depleted 
cells had significantly increased (Fig. 2 C). RAB5 knockdown 
did not significantly alter the cell cycle profile or survival of 
MDA-MB-231 cells (unpublished data); thus, it presumably 
affected the ability of these cells to extravasate, spread within, 
or adhere to lung tissue.
Next, we turned to MCF10.DCIS.com cells, which repro-
ducibly form comedo-type DCIS lesions that spontaneously 
progress to invasive tumors (Miller et al., 2000; Hu et al., 2008). 
We subcutaneously injected control and doxycycline-inducible 
RAB5AS34N-MCF10.DCIS.com cells. After 4 d, we fed mice 
with doxycycline and monitored tumor growth and progression to 
invasive disease over time. After 1 wk, control and RAB5AS34N 
tumors were comparable in size (Fig. S1 C) and presented the 
typical DCIS histology, with a core of cancer cells delimited 
by a smooth muscle actin (SMA)-positive myoepithelial layer 
(Fig. 2 D). However, although MCF10.DCIS.com control lesions 
lost the myoepithelial layer and progressed to become invasive 
tumors after 3 wk, RAB5AS34N-expressing cells maintained 
the typical DCIS histology and their invasiveness was signifi-
cantly impaired (Fig. 2 D).
To assess whether the elevation of RAB5A expression was 
sufficient to promote lung dissemination, we generated RAB5A-
expressing MCF10.DCIS.com (Fig. 2 E). Control and RAB5A-
MCF10.DCIS.com cells were labeled with a fluorescent vital 
dye, injected into mice tail vein, and monitored for their ability to 
colonize the host lung. A similar number of control and RAB5A-
expressing cells were present in the lung 2 h after injection 
(Fig. 2 E). However, after 96 h the number of RAB5A-MCF10.
DCIS.com cells was significantly higher than that of control cells 
(Fig. 2 E). RAB5A expression did not significantly alter the cell 
cycle profile or survival of MCF10.DCIS.com cells (unpub-
lished data); thus, it was sufficient to enhance the ability of these 
cells to extravasate and adhere to lung tissue.
Collectively, these data indicate that RAB5A function is 
required, at least in the used model systems, for breast cancer 
cells to acquire the hallmarks of aggressiveness, both at the 
level of local invasiveness and of metastatic ability.
RAB5A promotes dissemination in vivo  
and invasion in vitro of poorly invasive 
tumor cells
To assess whether elevation of RAB5A levels is also sufficient 
to promote metastatic behavior in other types of cancer, we 
turned to HeLa cells, which are poorly invasive and express low 
levels of RAB5A (Palamidessi et al., 2008; Liu et al., 2011). 
We engineered control and RAB5A-expressing HeLa cells to 
also stably and homogenously express GFP-LifeAct; an F-actin 
binding peptide (Riedl et al., 2008; Fig. S1 D). Next, we xeno-
grafted these cells into the mammary fat pads of NSG mice to 
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Figure 3. RAB5A is sufficient to promote intratumoral cell motility and distant dissemination. (A) GFP-LifeAct control (Ctr) or GFP-LifeAct-RAB5A-(RAB5A) 
HeLa cells were injected into the mammary fat pads of NSG mice. Metastases were analyzed 4 wk after removal of primary tumor. (A, left) Ipsilateral 
metastasis (arrowheads) of control or RAB5A-HeLa tumors. (A, right) Quantitation of number and volume (mean ± SEM [error bars]; n = 10 mice/group) 
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of disseminated tumors nodules. **, P < 0.005. (B, left) H&E and anti-GFP staining of FFPE lung tissue sections. Magnified boxed regions show metastasis. 
(B, right) The size of metastatic nodules is the mean tumor area/total lung area ± SEM (error bars; n = 9 mice/group repeated in two independent experi-
ments). **, P < 0.005. (C) Tumors from GFP-LifeAct control (Ctr) or GFP-LifeAct-RAB5A-(RAB5A)-HeLa cells injected into the mammary fat pads of NSG 
mice were analyzed by two-photon microscopy. Green, GFP-LifeAct; gray, collagen structure (SHG). (D) Tumor invasive front visualized: in the top panels 
by projecting 40 serial z sections (green, GFP-LifeAct; gray, collagen structure [SHG]; or, in bottom panels, by IHC. (E) Intratumoral motion analysis of 
control and RAB5A-HeLa cells was obtained by overlaying 10 differentially colored, consecutive frames of time-lapse recording (Videos 1 and 2; left). 
Coloring indicates motile cells. The percentage of motility events/field of view/tumor is the mean ± SEM (error bars; n = 45). Bars: (B, left) 2 mm; (B, right) 
0.2 mm; (C) 400 µm; (D, top) 200 µm; (D, bottom) 10 µm; (E) 80 µm.
 
establish tumors, and then monitored ipsilateral and distant me-
tastasis after removal of the primary tumor. In this assay, 
HeLa cells behaved similarly to MDA-MB-231 cells: the size, 
proliferation rate, and extent of apoptosis in control and RAB5A-
HeLa primary tumors were indistinguishable (Fig. S1 E). In con-
trast, there was a significant increase in both the number and 
size of ipsilateral and distant metastatic outgrowths originat-
ing from RAB5A-HeLa tumors, compared with control tumors 
(Fig. 3, A and B). We then performed intravital microscopy 
on the primary tumors. Control HeLa tumors were compact 
masses with defined tumor margins (Fig. 3, C and D). In con-
trast, RAB5A-HeLa tumors were composed of loosely adherent, 
scattered cells, with nonhomogeneous, ragged margins (Fig. 3, 
C and D). Importantly, whereas control HeLa cells displayed 
little motility within tumors, RAB5A-HeLa cells were elongated, 
with frequently extended pseudopodia protrusions (Videos 
1 and 2), rare circular structures that resembled circular ruffles 
observed on the dorsal surface of the cell in 2D (CDR), and blebs 
(Video 2). RAB5A-HeLa cells could also be seen migrating 
within the tumors (Fig. 3 E and Video 2).
To gain insights into how RAB5A controls motility pro-
grams, we monitored invasion into 3D matrices in vitro. We ini-
tially set up organotypic gels formed of acid-extracted rat-tail 
collagen preconditioned with human macrophages to recapitulate 
the tumor stroma (Nyström et al., 2005). Under these conditions, 
control HeLa cells survived, but barely entered into organotypic 
matrices over a 14-d period. In contrast, RAB5A-HeLa cells 
effectively invaded the matrix in a metalloprotease-dependent 
manner (Fig. 4, A and B). Inspection by second harmonic gen-
eration (SHG) of two-photon microscopy of the 3D organization 
of the collagen fibrillar meshwork revealed that RAB5A-HeLa 
cells extensively remodeled the network, generating spaces and 
gaps, and altering the parallel, orderly orientation of type I colla-
gen fibers (Fig. S1 F). We observed a similar remodeling of skin 
interstitial tissues around the xenografted tumors resulting from 
subcutaneous injection of RAB5A-HeLa, but not of control, 
cells (Fig. S1, G and H). Thus, ectopic RAB5A expression is 
sufficient to transform a poorly invasive HeLa-originated tumor 
into a collagen remodeling, invasive tumor.
To further corroborate this notion, we monitored in real 
time the invasive migration of tumor cells into 3D gels of native 
type I collagen (Hotary et al., 2003; Sabeh et al., 2004; Li et al., 
2008). Native, acid-extracted, type I collagen retains its telo-
peptide and, unlike pepsin-extracted collagens, polymerizes 
into a dense fibrillar network, which provides a formidable bar-
rier to invasion, unless cells acquire collagenolytic activity 
(Sabeh et al., 2009; see also Fig. S2 A and Video 3 [top] for 
assay standardization). Control HeLa cells could not enter into 
the native type I collagen matrix. However, RAB5A-HeLa read-
ily invaded and their invasiveness was abrogated by the broad 
spectrum metalloprotease inhibitor GM6001 (Fig. S2 B and 
Videos 3 and 4). Conversely, expression of RAB5AS34N in 
MDA-MB-231 (Fig. 4 C and Video 6) or MCF10.DCIS.com 
(Fig. 4 D and Video 6) cells almost completely arrested their 
invasive potential. A similar inhibition of invasion was achieved 
by siRNA-mediated silencing of the three RAB5 isoforms in 
MDA-MB-231 cells (Fig. S2 C and Video 6).
We next exploited the ability of MCF10.DCIS.com cells to 
generate invasive outgrowths in 3D basement membrane over-
lay assays (Lee et al., 2007). We plated control and doxycycline- 
inducible RAB5AS34N MCF10.DCIS.com cells as single cells 
onto a gel composed of Matrigel and type I collagen. As expected, 
control cells generated compact, acini-like structures, which upon 
addition of HGF formed heterogeneous structures with extended 
invasive outgrowths (Fig. 4 E; Jedeszko et al., 2009). The invasive 
outgrowths were abrogated by the expression of RAB5AS34N, 
which was induced by the addition of doxycycline at the same 
time as HGF (Fig. 4 E).
Thus, RAB5A is necessary and sufficient to promote a 
proteolytic mesenchymal program of cell invasion in vitro and 
tumor dissemination in vivo.
RAB5A is necessary and sufficient for 
invadosome formation
Invadosomes are actin-rich adhesive platforms that degrade ECM 
in invasive tumor cells (Linder et al., 2011). Indeed, both MDA-
MB-231 and MCF10.DCIS.com cells readily formed functional 
invadosomes upon HGF stimulation in vitro. Inhibition of RAB5 
by RAB5AS34N expression (Fig. 5, A and B), or siRNAs target-
ing the three RAB5 isoforms (Fig. S2 D), significantly reduced 
HGF-induced invadosome formation and matrix degradation in 
MDA-MB-231 and MCF10.DCIS.com cells as well as in other 
breast cancer cells (Fig. S2, E and F). Conversely, the elevation 
of RAB5A levels was sufficient to increase invadosomes for-
mation (Fig. S2 G).
Interestingly, HeLa cells, which are notoriously poor in 
degrading the ECM under growing conditions, also acquired this 
ability in response to HGF stimulation (Fig. S3, A and B). No-
tably, HGF addition acutely increased the levels of GTP-bound 
RAB5A (Fig. S3, A and B). Additionally, genetic or functional 
interference with RAB5 severely inhibited HGF-stimulated ma-
trix proteolysis (Fig. S4 A). Conversely, elevation of RAB5A 
was sufficient to induce actin-rich clusters on the ventral plasma 
membrane (PM) in unstimulated cells (Fig. 5, C and D). These 
structures represented bona fide invadosomes based on: (1) the 
presence of several prototypical invadosomal markers (Fig. S3 C), 
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Figure 4. RAB5A is necessary and sufficient to promote matrix-metalloprotease–dependent invasion into a 3D matrix. (A) RAB5A promotes organotypic 
cell invasion and remodels stromal collagen. (A, left) H&E-stained cross-sections of GFP-LifeAct control (Ctr) or GFP-LifeAct-RAB5A-(RAB5A) HeLa cells grown 
for 14 d on organotypic collagen matrix preconditioned with U937 macrophages, in the absence or presence of GM6001. Bar, 400 µm. (B) Quantifica-
tion of the number of invading cells/condition, with respect to the number of invading RAB5A-HeLa cells, is the mean invasion index ± SEM (error bars) of 
four independent experiments (n = 45). *, P < 0.01. (C and D) Doxycycline-induced control- and RAB5AS34N-MDA-MB-231 (C) or RAB5AS34N-MCF10 
.DCIS.com (D) cells were assessed for their invasiveness by placing them on one side of a chamber slide in which 2.3 mg/ml acid extracted–only polym-
erized type I collagen gel and 100 ng/ml HGF were added. Examples of cell migration tracks are shown on the left (Videos 5 and 6). (C and D, right) 
Cell invasion is expressed as the mean forward invasion index ± SEM (error bars; n = 75 single cells/experiment repeated in four independent assays). 
*, P < 0.01; **, P < 0.005. (E) Doxycycline-inducible control (empty) or RAB5AS34N-MF10.DCIS.com cells were grown on a thick 1:1 Matrigel/type I 
collagen mixture and overlaid with diluted Matrigel (2 mg/ml). After 1 wk, cells were treated with doxycycline and/or HGF (20 ng/ml), or were mock 
treated. Bars, 400 µm. (E, right) The percentage of structures with invasive outgrowths was expressed as mean ± SEM (error bars) of four independent 
experiments; n = 35. **, P < 0.005.
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Figure 5. RAB5A is essential for HGF-induced invadosome formation. (A and B) Doxycycline-induced control and RAB5AS34N-MDA-MB-231 (A) or 
RAB5AS34N-MCF10.DCIS.com (B) cells plated onto fluorescently conjugated gelatin were stimulated with HGF (100 ng/ml) for 3 h. (B, left) Images of cells 
stained with phalloidin (left), fluorescently conjugated gelatin (middle), and merged channels (right). (B, right) Quantification of gelatin degradation was 
expressed as a degradation index (calculated as described in Materials and methods). Data are the mean ± SEM (error bars; n = 70 cells/experiment in 
five independent ones). **, P < 0.005. (C, left) TIRF microscopy of RAB5A-HeLa cells. F-actin and RAB5A were detected with phalloidin and anti–RAB5 Ab 
(RAB5), respectively. (C, right) xz sections of control and RAB5A-HeLa cells plated onto fluorescently conjugated gelatin (red) and stained with phalloidin 
(green). (D) Control and RAB5A-HeLa cells were plated onto fluorescently conjugated gelatin (middle) overnight under serum-starved conditions and stimu-
lated with suboptimal doses of HGF (1 ng/ml). F-actin and RAB5A were detected with phalloidin and anti-RAB5A Ab (RAB5A), respectively. Insets show 
magnifications of the boxed regions. Arrows indicate invadosomes. (D, right) Gelatin degradation was expressed as a degradation index (see Materials 
and methods). Data are the mean ± SEM (n = 50 cells/experiment in four independent ones). **, P < 0.005. Bars: (A–C) 20 µm; (D) 10 µm.
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to nascent invadosomes. Consistently, silencing of MT1-MMP 
abrogated HGF- and RAB5A-induced matrix degradation and 
reduced the number of invadosomes (Fig. S5, A and B). As HeLa 
cells express low levels of MT1-MMP (Zhai et al., 2005), we 
used fluorescently tagged MT1-MMP to facilitate its visualiza-
tion. In unstimulated cells, MT1-MMP could be detected on 
the ventral PM by TIRF microscopy (Video 6) and inside vesicles 
(Figs. S5 C and S6 D). As previously reported (Remacle et al., 
2003), a sizable fraction of these vesicles represented early 
EEA1-positive endosomes, which were also positive for RAB5, 
RAB4, and RABENOSYN-5 (Fig. S5 C). These vesicles could 
also be observed in cells embedded in 3D collagen (Fig. S5 D). 
Importantly, we confirmed the localization of endogenous MT1-
MMP into EEA1-, RABENOSYN-5–, and RAB4-positive endo-
somes in MCF10.DCIS.com cells (Fig. S5 E). Notably, in these 
cells, only a fraction of MT1-MMP localizes in LAMP-1–positive 
late endosomes (Fig. S5 E). Additionally, after treatment with 
HGF, or ectopic RAB5A expression, MT1-MMP relocalized 
to ventrally restricted, F-actin–rich structures (Video 6), which 
were also transiently targeted by RAB5A- and RAB4A-positive 
early endosomes (Fig. S5 F and Video 7).
These results suggest that fast recycling of MT1-MMP is 
essential for HGF- and RAB5A-induced invadosome forma-
tion. To provide direct evidence for this possibility, we used an 
antibody that recognizes the extracellular domain of MT1-MMP 
to follow recycling of preinternalized metalloprotease back to the 
PM. HGF stimulation significantly increased the mobilization 
rate of MT1-MMP, with >60% recycling occurring after 2 min 
of stimulation (Fig. 7 A). HGF-induced recycling of MT1-MMP 
was reduced by silencing of RAB5, RAB4, and RABENOSYN-5, 
but not of integrin 3 expression (see the following paragraph; 
Fig. 7 A), under conditions in which the steady-state amounts 
of cell surface MT1-MMP were not altered (Fig. 7 B). Only 
RAB5 loss impaired MT1-MMP internalization (Fig. 7 C), which 
suggests that the primary effect of RAB5 is to impede entry into 
the early endosome from which MT1-MMP is subsequently re-
cycled through a RAB4–RABENOSYN-5 pathway.
Thus, after HGF stimulation, MT1-MMP is redirected to 
defined areas of the PM, namely to invadosomes, primarily via 
a RAB4 fast recycling route.
Genetic and functional interference with 
V3-, but not 1-containing integrins 
inhibits matrix degradation
Invadosomes are integrin-based adhesive, mechanosensory mod-
ules. Although different integrins localize to invadosomes, a major 
role has been attributed to 1 and 3 integrins in invadosome 
formation (for review see Destaing et al., 2011). To dissect the role 
of 1 and 3 integrins in RAB5A-induced invadosomes, we 
initially studied their localization in RAB5A-expressing HeLa 
cells. Both integrins localized on the ventral PM in serum-starved 
cells (Video 8). However, only V3, but not 1, integrin co-
localized with RAB5A-induced invadosomes both by confocal 
(Fig. 8 A) and TIRF analysis (Fig. 8 B and Video 8).
Notably, V3 is primarily recycled through the RAB4 
pathway (Roberts et al., 2001), similar to what we report here 
for MT1-MMP. This suggests that the two proteins may be 
(2) their dependency on the nucleation promoting factor, 
N-WASP (Yamaguchi et al., 2005; Fig. S4, D and E), and (3) 
their ability to focally degrade the ECM (Fig. 5, C and D).
Thus, RAB5A is necessary and sufficient to promote 
invadosome formation and focal matrix degradation activity in 
response to stimulation with motogenic factors.
The RAB4-dependent recycling route is 
essential for invadosome formation
We used a molecular genetics approach to dissect the circuitry 
involved in the formation of HGF (or RAB5A)-induced inva-
dosomes. We performed this screening in HeLa cells, which can be 
efficiently transfected and induced to form CDRs and invadosomes 
by either HGF stimulation or the expression of RAB5A (Palamidessi 
et al., 2008). Interference with the major internalization routes by 
inhibition of clathrin or dynamin, or with recycling pathways by 
reducing the temperature to 16°C, reduced both RAB5A-induced 
invadosomes and CDRs (Table S1). Similar inhibition of both 
these structures was achieved by silencing of ARF6 and RAB35, 
which are involved in membrane recycling (Palamidessi et al., 
2008; Svensson et al., 2008; Zhang et al., 2009; Table S1). In con-
trast, the inhibition of the fast recycling route by interference with 
RAB4 or its effector RABENOSYN-5 prevented the formation of 
invadosomes, but not of CDRs (Table S1). Finally, impairment of 
the RAB11-dependent slow recycling, RAB7-mediated degra-
dative, or RAB8-biosynthetic secretory exocytic pathways had no 
effect on the formation of invadosomes or CDRs (Table S1).
We next determined whether RAB4 and RABENOSYN-5 
were also necessary for HGF-induced matrix degradation. Si-
lencing of the two RAB4 isoforms (A and B), or expression of a 
dominant-negative RAB4A mutant reduced (>80%) the number 
of invadosomes and matrix degradation (Fig. S4, A and B). Simi-
lar effects were obtained by silencing RABENOSYN-5, whereas 
suppression of RAB11 activity had no effect (Fig. S4, A and B).
We also validated these findings in breast cancer cell 
models. Like in HeLa cells, silencing of RAB4 (or expression of 
RAB4AS22N) or of RABENOSYN-5, but not of RABAPTIN-5, 
impaired matrix proteolysis of MCF10.DCIS.com (Fig. 6, 
A and B). A similar impairment in matrix degradation was 
also observed in MDA-MB-231 upon interference with RAB4A 
and -B (Fig. S4, C and D). Thus, growth factor–induced RAB5-
dependent invadosomes require a functional RAB4–RABENO-
SYN-5 recycling pathway. The critical role of RABENOSYN-5 
should depend on its ability to physically and simultaneously bind 
to activated RAB5 and RAB4. Accordingly, although the expres-
sion of a siRNA-resistant RABENOSYN-5 wild-type protein 
restored matrix degradation of RABENOSYN-5 knockdown cells 
(Fig. 6, C and D), siRNA-resistant RABENOSYN-5 mutants 
impaired either in the binding to RAB5 or to RAB4 (Eathiraj 
et al., 2005) failed to do so (Fig. 6, C and D).
RAB5A- and HGF-mediated matrix 
degradation requires RAB4-dependent fast 
recycling of MT1-MMP
The requirement of RAB5- and RAB4-dependent fast EECs for 
invadosome formation suggests that a membrane-associated matrix 
degradative cargo, most likely MT1-MMP, should be delivered 
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Figure 6. The RAB4–RABENOSYN-5 recycling pathway is necessary for HGF-induced invadosome formation. (A) Serum-starved MCF10.DCIS.com cells, 
transfected with scrambled siRNA (Ctr), siRNAs against RABENOSYN-5 (siRNA RBNS-5) or RAB4A and -B (siRNA RAB4), or RABAPTIN-5. GFP-RAB4AS22N-
MCF10.DCIS.com cells were induced or not induced with doxycycline and serum starved. Cells were plated onto fluorescently conjugated gelatin (green), 
stimulated with HGF for 3 h, or left in serum free conditions (SF), and stained with phalloidin (red). Bar, 15 µm. (A, left) GFP-RAB4AS22N (GFP-RAB4A) 
expression was verified by immunoblotting. (B) Gelatin degradation was expressed as a degradation index. Data are the mean ± SEM (error bars; n = 75 
cells/experiment in four independent ones). *, P < 0.01. Silencing of RAB4A, RAB4B, and RABENOSYN-5 genes was performed using two independent 
siRNA oligos, which gave identical results (not depicted), and was verified by QRT-PCR (right). **, P < 0.005. (C) MCF10.DCIS.com cells were cotransfected 
with scrambled siRNA (Ctr) or siRNAs against RABENOSYN-5 (siRNA RBNS-5) together with siRNA-resistant RABENOSYN-5 wild type (resWT-RBNS-5) 
or mutants impaired in binding to RAB4 (resRAB4--RBNS-5) or to RAB5 (resRAB5--RBNS-5), or to both GTPases (resRAB4/5--RBNS-5) fused to GFP. 
Cells were plated onto fluorescently conjugated gelatin (red), stimulated with HGF for 3 h, or left in serum free conditions, and stained with DAPI (blue). 
Arrows, matrix degradation areas. Bar, 20 µm. (D) Gelatin degradation is expressed as a degradation index, as indicated in B. Data are the mean ± SEM (error 
bars; n = 65 cells/experiment in three independent ones). *, P < 0.01. Silencing of RABENOSYN-5 was verified by QRT-PCR (right). **, P < 0.005.
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Figure 7. HGF-induced fast recycling of MT1-MMP depends onto RAB5, RAB4, and RABENOSYN-5. (A) Cherry-MT1-MMP–expressing HeLa cells were 
transfected with scrambled siRNA or siRNAs against RAB5A,B,C (siRNA-RAB5) or RAB4A and -B (siRNA RAB4 A/B), RABENOSYN-5 (siRNA RBNS-5), 
or integrin 3 (siRNA 3). Serum-starved cells were incubated with anti–MT1-MMP antibody at 16°C for 2 h. After a mild acid wash to remove surface 
antibody, cells were switched to 37°C and stimulated with HGF (100 ng/ml), or left in serum free (SF) conditions. At the indicated time points, cells 
were fixed, and stained in the absence of permeabilization with FITC-conjugated secondary antibody (green). Cherry-MT1-MMP (red) was detected by 
epifluorescence. The relative cell surface levels of MT1-MMP were quantified using ImageJ software on nonsaturated images, and expressed as relative 
cell surface MT1-MMP levels with respect to HGF-stimulated control cells after 15 min (set at 100%). Data are the mean ± SEM (error bars; n = 25 cells 
repeated in three independent experiments). (B) Steady-state cell surface levels of MT1-MMP. Cherry-MT1-MMP-HeLa cells were transfected with scrambled 
siRNA or siRNAs against RAB5A,B,C (siRNA-RAB5) or RAB4A and -B (siRNA RAB4 A/B), RABENOSYN-5 (siRNA RBNS-5), or integrin 3 (siRNA 3). 
Cells were incubated with anti–MT1-MMP antibody at 4°C for 2 h, washed, fixed, and stained in the absence of permeabilization with FITC-conjugated 
secondary antibody (green). (C) Silencing of RAB5 impairs MT1-MMP internalization. Cherry-MT1-MMP-HeLa cells were transfected with scrambled (Ctr) 
or anti-RAB5A,B,C siRNAs. Serum-starved cells were incubated with anti–MT1-MMP antibody at 16°C for 2 h. Cells were washed, fixed, permeabilized 
with 0.1% Triton X-100, and stained with FITC-conjugated secondary antibody (green). Bottom right, efficacy of gene silencing by QRT-PCR. Data are the 
mean ± SEM (error bars). **, P < 0.005. Bars, 10 µm.
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Figure 8. Genetic and functional interference with V3, but not 51, integrin inhibits RAB5A- and HGF-induced invadosome formation and matrix 
degradation. (A) Confocal analysis of RAB5A-HeLa cells stained with phalloidin (red) or the indicated Ab (green). (B) Still images from TIRF microscopy 
time-lapse of HeLa cells transfected with RAB5, GFP-3, and RFP-LifeAct (see also Video 8). (C) HeLa cells cotransfected with RAB5A and MT1-MMP were 
subjected to PLA (red dots) with abs against MT1-MMP and integrin 3 or stained with phalloidin (green). Negative controls (Ctr) were cells stained with 
oligonucleotide-labeled PLA probes alone. Confocal images in A, B, and C are representative of >100 analyzed cells. (D) HeLa cells were transfected with 
scrambled (Ctr), anti-1, or anti-3 siRNA, or incubated with the inhibitory antibodies, 4B4 and LM609, against 1 and V3, respectively. Serum-starved 
cells were plated onto fluorescently conjugated gelatin (red), stimulated with HGF (100 ng/ml) for 3 h, or left in serum free conditions (SF), and stained 
with phalloidin (green). Insets are magnifications of boxed regions. Quantification of gelatin degradation was expressed as a degradation index (relative 
to the area of degradation of control, HGF-stimulated cells normalized for cell number). Data are the mean ± SEM (error bars; n = 60 cells/experiment in 
five independent experiments). Two independent siRNAs were used for each integrin with similar results. Silencing of 1 and 3 genes was verified by 
QRT-PCR (right). **, P < 0.005. Arrows in A–D indicate examples of invadosomes. (E) MDA-MB-231 and MCF10.DCIS.com cells were transfected with 
scrambled (Ctr) or anti-3 siRNA. Serum-starved cells were then plated onto fluorescently conjugated gelatin (red), stimulated with HGF (100 ng/ml) for 3 h, 
or left in serum free conditions (SF), and stained with phalloidin (green). Gelatin degradation is expressed as a degradation index. Data are the mean ± SEM 
(error bars; n = 40 cells/experiment in three independent ones). Two independent siRNAs were used for each integrin with similar results. Silencing 3 
genes was verified by QRT-PCR (right). **, P < 0.005. Bars: (A) 15 µm; (B–E) 20 µm.
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progression and whether it may act as a driver of tumorigenesis, 
our results suggest that this event is selected in human tumors 
and may contribute to their invasive phenotype.
Discussion
This study demonstrates that RAB5A/RAB4-dependent EECs 
control the execution of metalloprotease-mediated invasive pro-
grams. RAB5A, acting through the RAB4 fast recycling pathway, 
is necessary and sufficient to redirect adhesive (3 integrin) and 
proteolytic molecules (MT1-MMP) to invadosomes, thus allow-
ing their maturation into fully competent ECM degrading struc-
tures. Previously, we demonstrated that RAB5-dependent EECs 
are also indispensable for the spatial restriction of signals leading 
to the formation of PM protrusions, and the acquisition of mesen-
chymal motility (Palamidessi et al., 2008). Thus, RAB5 orches-
trates the execution of the key events in the mesenchymal program 
of invasion: invadosome formation and maturation, actin remod-
eling, and mesenchymal cell motility. The inducibility of this pro-
gram by growth factors, such as HFG or EGF, argues in favor of 
its physiological significance. However, the most relevant im-
pact of this pathway appears to be on the acquisition of an inva-
sive phenotype by metastatic cancer cells, as demonstrated by our 
analysis in invasive-metastatic models, and supported by findings 
in naturally occurring tumors. We propose, therefore, that RAB5 
is a master regulator of tumor invasion programs.
RAB5A controls recycling of MT1-MMP  
to the PM and its activation
Invadosomes can be induced as a result of mechanosensing or 
upon stimulation with motogenic soluble factors. In the former 
case, invadosome formation can be considered as a “default re-
sponse” that is triggered when tumor cells adhere to the ECM 
and sense matrix rigidity (Alexander et al., 2008). MT1-MMP 
is the key effector in this circuitry, as matrix rigidity is suffi-
cient to induce its mobilization from intracellular compart-
ments toward the PM (Alexander et al., 2008). This event has 
been shown to require RAB8-dependent polarized exocytosis 
(Bravo-Cordero et al., 2007), though it is less clear whether the 
originating compartment is represented by the classic biosyn-
thetic/secretory pathway or by the recycling endosomal station 
(Poincloux et al., 2009). Late endosomal recycling (Steffen 
et al., 2008; Monteiro et al., 2013) of MT1-MMP as well as 
exosome secretion (Hoshino et al., 2013) can also contribute to 
the local delivery of this protease (Steffen et al., 2008; Williams 
and Coppolino, 2011; Monteiro et al., 2013). Similarly, we found 
that interference with late endosomal routes by silencing RAB7 
reduced, but did not abrogate, RAB5-dependent invasion into 
dense collagen matrix (unpublished data). This implies that a frac-
tion of MT1-MMP is sorted from early to late endosomes before 
PM delivery and is consistent with the notion that a cargo can use 
different trafficking routes depending on cell types, extracellular 
stimuli, and micro environmental conditions (Yamaguchi et al., 
2005; DesMarais et al., 2009; Frittoli et al., 2011).
We demonstrated here that HGF is a potent inducer of in-
vadosome formation, and this process is exquisitely dependent 
on RAB5A/RAB4 EECs. Thus, the default and inducible modes 
cotrafficked to invadosomes in response to HGF. In support of 
this possibility, we showed by proximity ligation in situ that 
MT1-MMP and V3 partially colocalized in punctate struc-
tures in the cytoplasm, as well as on ventral actin clusters (inva-
dosomes) upon HGF stimulation (Fig. 8 C). Finally, we interfered 
with the activity V3 and 1 integrin using specific inhibi-
tory antibodies or siRNAs. In the case of V3, but not of 1 
integrins, this led to the impairment of HGF-induced, RAB5A-
dependent invadosomes formation and matrix degradation in 
HeLa (Fig. 8 D), as well as in MDA-MB-231 and MCF10.
DCIS.com (Fig. 8 E). Of note, the extent of MT1-MMP recy-
cling to the PM was independent of integrin 3 (Fig. 7 A), which 
indicates that this integrin is likely required for the localized 
PM targeting, but not for the trafficking of MT1-MMP.
RAB5A and RAB4A promote  
MT1-MMP– and 3-dependent cell invasion  
into 3D matrices
Our current and previously published data (Palamidessi et al., 
2008) support a model in which RAB5 couples elongated protru-
sions with pericellular proteolysis by controlling RAB4-dependent 
fast recycling of MT1-MMP and 3 integrin cargos to enable 
efficient invasion. We verified this model by monitoring in real 
time the chemotactic invasion of RAB5A-HeLa cells, in which 
MT1-MMP, RAB4A/B, or 1 or 3 integrin expression had been 
inhibited, into 3D native type I collagen gels containing HGF. 
RAB5A-dependent invasion was impaired by silencing of MT1-
MMP, RAB4A/B, and 3 integrin, but only marginally affected 
by silencing of 1 integrin (Fig. 9 A and Video 9). Silencing of 
RAB4A/B and 3 integrin also impaired MDA-MB-231 inva-
sion (Fig. 9 B and Video 10).
To assess whether interference with RAB4 impacted the 
invasive behavior of breast cancer cells in vivo, we generated 
doxycycline-inducible RAB4AS22N-expressing MCF10.DCIS.
com cells. First, we verified that RAB4AS22N impaired invasive-
ness of these cells into collagen type I matrix in vitro (Fig. 9 C 
and Video 10). Next, we injected control and RAB4AS22N-
MCF10.DCIS.com cells into immunodeficient mice and moni-
tored tumor progression to invasive disease over time. After 1 wk, 
control and RAB4AS22N-tumors were comparable in size and 
presented the typical DCIS histology (Fig. 9 D). However, while 
MCF10.DCIS.com control lesions lost the myoepithelial layer and 
progressed to become invasive tumors after 3 wk, RAB4AS22N-
expressing cells maintained the typical DCIS histology and their 
invasiveness was impaired (Fig. 9 D).
Prompted by this set of findings, we investigated the matter 
by manually querying the Cancer Genome Atlas (TCGA) data-
base. This analysis revealed that RAB4A is amplified in various 
tumors (Fig. 10 A). In invasive breast carcinoma, RAB4A is the 
most frequently amplified RAB GTPase (13.7%; Fig. 10 B). 
Consistently, analysis of RAB4A expression by IHC in a gen-
eral tumor tissue microarray confirmed that RAB4A levels are 
significantly more elevated in various tumors, and most notably 
in breast cancers, as compared with their normal epithelial tis-
sue (Fig. 10 C and Table S2). Although an analysis in a larger 
cohort of primary and metastasis samples would be necessary 
to establish the relevance of RAB4A elevation on breast cancer 
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Figure 9. The RAB5A/RAB4A circuitry promotes 3D matrix invasion in an MT1-MMP– and 3 integrin–dependent manner, and is dysregulated in 
invasive breast cancer. (A) RAB5-HeLa cells were transfected with the indicated siRNAs or scrambled control (Ctr), and tested for invasion as described in 
Fig. 4 (C and D). (A, top) Examples of cell migration tracks (see Video 9). (A, bottom) Quantification of cell invasion is the mean forward invasion index ± 
SEM (error bars; n = 60 cells/experiment/siRNA repeated in four independent assays). *, P < 0.05; **, P < 0.005. Gene silencing was verified by QRT-
PCR (bottom right). **, P < 0.001. (B) MDA-MB-231 cells were transfected with the indicated siRNAs or scrambled control (Ctr) and tested for invasion 
as described in Fig. 4 (C and D). (B, left) Examples of cell migration tracks (see Video 10). Quantification of cell invasion is expressed (right) as the mean 
forward invasion index ± SEM (error bars; n = 40 cells/experiment/siRNA repeated in three independent invasion assays). *, P < 0.05; **, P < 0.005. 
Silencing of the different genes was verified by QRT-PCR (right). **, P < 0.001. (C) Control and RAB4AS22N-MCF10.DCIS.com cells were induced with 
doxycycline and tested for invasion as described in Fig. 4 (C and D). (C, left) Examples of cell migration tracks (Video 10). (C, right) Quantification of 
cell invasion is the mean forward invasion index ± SEM (error bars; n = 45 cells/experiments in two independent experiments). (D) Doxycycline-inducible 
RAB4AS22N- and control-MCF10.DCIS.com cells were injected subcutaneously into NSG mice. After 2 d, mice were fed with doxycycline. Histological 
(H&E) and IHC analyses with anti– smooth muscle actin (SMA) of control (Ctr) and RAB4AS22-MCF10.DCIS.com xenografts were performed at 1 and 
3 wk after doxycycline treatment. Images are from three independent experiments (n = 6 mice/experimental condition). Bars, 100 µm.
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Figure 10.  RAB4A is amplified in invasive breast cancer. (A) RAB4A is amplified in various tumors. The cBio Cancer Genomics Portal (http://www 
.cbioportal.org/public-portal/) was queried for RAB4A across various tumor datasets. The alteration frequency, type of alterations of RAB4, availability 
of mutation analysis, and Copy Number Alteration (CNA) in the various tumor cohorts are shown. (B) RAB4A is, among the RAB family members, the 
most frequently amplified gene in invasive breast carcinoma. The percentage of each RAB gene amplification in invasive breast carcinoma reported in the 
Cancer Genome Atlas (TCGA) is shown. Only the genes with a frequency of amplification >5% are shown. (C) RAB4A is overexpressed in breast cancer. 
Shown are examples of the data of Table S2. Circled areas are enlarged below. Bars, 100 µm.
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of invadosome formation might represent two sides of the same 
“signaling” coin: adhesion- and RTK-stimulated, respectively. 
Based on our data, these pathways appear to converge on RAB5A 
and RAB5A-controlled delivery of MT1-MMP to spatially de-
fined regions of the PM. This possibility is corroborated by evi-
dence that fast and slow EEC-mediated turnover of MT1-MMP 
at the PM is critical to sustain matrix degradation (Hoshino 
et al., 2012) and further reinforce the notion that RAB5A is a 
pivotal regulator of the invasive program.
RAB5A couples migratory and  
invasive protrusions
Cell migration is a four-step process involving actin-propelled 
leading edge protrusions, transient formation of integrin-mediated 
focal attachment to the substrates, actomyosin-mediated cell 
contraction for rear-end retraction, and forward sliding of the 
cell body (Lauffenburger and Horwitz, 1996). This model is 
sufficient to describe the events necessary for 2D migration. 
However, in vivo, cells need to deal with the physical constraints 
of 3D stromal tissues, which are particularly challenging under 
situations where the stromal ECM is organized as a dense mesh-
work. Under these conditions, individual tumor cells must acti-
vate pericellular proteolytic activity for ECM degradation and 
remodeling, and integrate this activity within established steps 
of cell migration.
How this integration is achieved has so far remained elu-
sive. Based on the present data and our previously published 
work, we can conceive a model for integration, in which RAB5 
early endosomes represent the signaling platform where proteo-
lytic and migratory cues converge to then be transmitted to the 
cell in an interpretable, spatially restricted fashion. Indeed, we 
provide evidence that RAB5-dependent EECs are critical to the 
delivery of MT1-MMP and 3 integrin to spatially restricted 
regions of the PM where invadosomes form. Previously, we 
demonstrated that RAB5-dependent recycling is required and 
sufficient for the delivery of active RAC1 to specific regions of 
the PM, which imparts spatial restrictions on HGF signaling 
and leads to the polarized generation of actin-based cellular 
protrusions (Palamidessi et al., 2008). Thus, RAB5-EECs coor-
dinate all the known steps required for the execution of a suc-
cessful migratory/invasive program.
RAB5A/RAB4-EECs and MT1-MMP  
in tumor dissemination
Cancer progression is accompanied and promoted by MMP-
dependent ECM remodeling and desmoplasia (Sternlicht et al., 
1999). Genetic or pharmaceutical inhibition impairment of 
MMPs, and specifically of MT1-MMPs, reduces breast metas-
tasis (Hotary et al., 2003, 2006; Martin et al., 2008). Neverthe-
less, clinical trials targeting MMPs have failed, which suggests 
that the role of MMPs in cancer is more complicated (Coussens 
et al., 2002). Indeed, there is a dynamic and reciprocal rela-
tionship between ECM deposition, processing, degradation, 
and malignant progression. Cancer is best viewed as a dynamic, 
phenotypically plastic, and highly coordinated tissue remodel-
ing process that is tightly regulated by biochemical and me-
chanical cues (Friedl and Alexander, 2011). RAB5 and RAB4 
endosomes may serve as intracellular hubs that integrate diverse 
cell-autonomous responses to both soluble and insoluble micro-
environmental cues. This would enable fast adaptation of the 
migratory strategy and ultimately promote tumor cell dissemi-
nation. It is thus not surprising that elevation of RAB5A and/or 
amplification of RAB4A may be selected events in a subset of 
breast cancers to increase their metastatic potential.
Materials and methods
Plasmids, antibodies, and reagents
The plasmids pCDNA3–RAB5AS34N-Myc, pCMV–RABA and pCDNA3–
RAB5AQ79L-Myc were gifts from M. Zerial (Max Planck Institute, Dresden, 
Germany). pCFP-RAB5A was gift from A. Sorkin (University of Pittsburgh 
School of Medicine, Pittsburgh, PA). pCDNA-RAB4AS22N was a gift from 
P. van der Sluijs, University Medical Center Utrecht, Utrecht, The Neth-
erlands). pEGFP-DYNAMIN2-K44A was a gift from P. De Camilli (Yale 
School of Medicine, New Haven, CT). pSR2ARF6T44N and pCDNA3.1-
cherry MT1-MMP were gifts from P. Chavrier (Institute Curie, Paris, France). 
pCDNA3-MT1-MMP was a gift from R. Béliveau (Université du Québec 
à Montréal, Montréal, Québec, Canada). pEGFP-RAB11S22N, pEGFP-
RAB4, pEGFP-RABENOSYN5, and pCDNA3-RAB35S22N were gifts from 
B. Goud (Institute Curie, Paris, France). pEGFP vector was from Takara 
Bio Inc.
For lentiviral infection, RAB5AWT, RAB5AS34N, and GFP-RAB4AS22N 
were cloned in the TET ON pSLIK vector.
pEGFP-res WT-RABENOSYN5 containing silent mismatches in the 
target sequence of RABENOSYN5 oligo 2 (GGTCTATaATGTGCAAaAAGT-
GTAT), pEGFP-res RAB4--RABENOSYN5 (W443A), pEGFP-res RAB5--
RABENOSYN5 (I734E), and pEGFP-res RAB4/5--RABENOSYN5 (W443A 
and I734E) were provided by Mutagenex Inc.
Antibodies used were: rabbit anti-RAC 1/2/3 and anti-Caspase3 
(Cell Signaling Technology); mouse anti-HA1 (BabCo); rabbit anti-RAB5A 
(S-19), anti–Integrin 3 (H96), anti-GFP (FL), mouse monoclonal anti-ARP3 
(4), and goat anti-EEA1 (N-19; all from Santa Cruz Biotechnology, Inc.); 
mouse monoclonal anti-clathrin (X22; Thermo Fisher Scientific); mouse 
monoclonal anti-FAK and anti-VASP (BD); anti-Actin (AC-40); anti-LAMP1; 
anti-SMA ( smooth muscle actin); mouse monoclonal anti– Tubulin and 
anti-RAB4 (1C10; both from Sigma-Aldrich); rabbit anti-GFP (Takara Bio 
Inc.); anti-Cortactin (4F11; EMD Millipore); mouse monoclonal anti–MT1-
MMP (LEM-2/15.8; EMD Millipore); mouse monoclonal anti-v/3 (LM609) 
and anti-5/1 (P1D6; Immunological Sciences); mouse monoclonal anti-
1 (4B4; Beckman Coulter); rabbit anti-Rabenosyn5 (No. 155247; Abcam); 
and rabbit anti–human Vimentin (Vector Laboratories). Mouse monoclonal 
anti-Myc (Hybridoma No. 9E10) was produced in-house in our departmen-
tal antibody facility and was raised against a AEEQKLISEEDLLRKRREQLKH-
KLEQLRNSCA synthetic peptide of Myc. Rabbit polyclonal anti–N-WASP 
antibody raised against a full-length, Sf9-expressed rat N-WASP was pro-
vided by M. Kirschner (Harvard Medical School, Boston, MA).
The following materials were used: recombinant human HGF (R&D 
Systems); GM6001 (EMD Millipore); rat-tail type I collagen High Concen-
tration (BD); purified bovine atelo-collagen (PureCol; Advanced BioMa-
trix); Matrigel Basement Membrane Matrix High Concentration (BD); 
TRITC/FITC-phalloidin (Sigma-Aldrich); Alexa Fluor 594 protein labeling 
kit, carboxyfluorescein succinimidyl ester (CFSE), and eFluor 670 (Molecu-
lar Probes); Avertin and Trypan blue solution (Sigma-Aldrich); and Picrosir-
ius Red (Polysciences, Inc.).
Cell lines
HeLa, HT1080, BT-20, BT-549, SUM-149, HCC-1428, HS-578T, 4T1, 
U937, and MDA-MB-231 cells were obtained from ATCC and grown ac-
cording to ATCC specifications. MCF10.DCIS.com were described in Miller 
et al. (2000).
CDR and invadosome assays
To assess the formation of CDRs and invadosomes, two observers evalu-
ated duplicate slides independently, and at least 200 cells per experimen-
tal condition were analyzed. Data are reported as a ruffling or invadosomes 
index, normalized to an internal control assumed to be 1 (indicated in the 
figure legends), and are the mean of at least three experiments performed 
in duplicate. In absolute terms, in RAB5A-expressing HeLa cells, 20% 
and 40% of the cells formed CDRs and invadosomes, respectively. In 
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treated with antibiotics to kill macrophages and rinsed. We used macro-
phages instead of fibroblasts, since these cells are known to associate with 
growing tumors, and they can modify the ECM and release significant 
amounts of motogenic factors, including EGF and HGF (Qian and Pollard, 
2010; Mantovani et al., 2011). GFP-LifeAct-HeLa cells (2 × 104), express-
ing RAB5 or empty vector as control, were plated on the top of the matrix 
in complete medium. The gel was then mounted on a plastic bridge and 
fed from underneath with complete medium (changed daily). After 14 d, 
the cultures were fixed with 4% PFA, paraffin embedded, and processed 
by standard methods for hematoxylin and eosin (H&E) staining. The inva-
sion index was calculated by measuring the number of H&E-stained control 
and RAB5A-HeLa cells that invaded a fixed area of the organotypic gel 
using the gel upper border as the upper limit. At least 10 areas along the 
organotypic gel were examined in at least two independent experiments. 
The error bars represent the SEM.
Organotypic outgrowths in 3D Matrigel
For the analysis of invasive outgrowth of MCF10.DCIS.com cells, an over-
lay basement membrane assay was carried in the presence of HGF, as 
described previously (Jedeszko et al., 2009). In brief, 6-well plates were 
coated with 12 mg/ml native Matrigel (BD) and allowed to solidify for 
20 min at 37°C. MCF10.DCIS.com cells (3.0 × 105) were seeded as sin-
gle cells onto the solidified basement membrane. Cultures were grown in 
M171 Mammary Epithelial Medium (Invitrogen) supplemented with Mam-
mary Epithelial Growth Supplement (Invitrogen) and 2% Matrigel. After 
7 d, cells were incubated with doxycycline and 20 ng/ml of HGF. Medium 
was replenished every 2 d. MCF10.DCIS.com were imaged in triplicate for 
development of invasive outgrowths by differential interference contrast (DIC) 
imaging using a 20× objective lens. Invasive outgrowths were defined as 
consisting of two or more cells migrating away from their structure of origin. 
A minimum of 20 images were analyzed for each experimental condition.
Quantitative RT-PCR analysis
Total RNA was isolated with the RNeasy kit method (QIAGEN). 2 µg of 
RNA were used, with 100 ng of random hexamers, in a reverse-transcription 
reaction (Superscript Vilo; Invitrogen). 0.1 ng cDNA was amplified, in trip-
licate, in a reaction volume of 25 µl with 10 pMol of each gene-specific 
primer and the SYBR-green PCR MasterMix (Applied Biosystems). Real-time 
PCR was performed on the 14 ABI/Prism 7700 Sequence Detector System 
(PerkinElmer/Applied Biosystems), using a pre-PCR step of 10 min at 95°C, fol-
lowed by 40 cycles of 15 s at 95°C and 60 s at 60°C. Specificity of the ampli-
fied products was confirmed by melting curve analysis (Dissociation Curve TM; 
PerkinElmer/Applied Biosystems) and by 6% PAGE. Preparations with RNA 
template without reverse transcription were used as negative controls. Sam-
ples were amplified with primers for each gene (for details see the Q-PCR 
primer list below) and ribosomal RNA 18S as a housekeeping gene. The 
Ct values were normalized to the 18S curve. The 18S gene was used as a 
control gene for normalization. Results were quantified using the 2CT method 
(Livak and Schmittgen, 2001). PCR experiments were performed in triplicate, 
and standard deviations calculated and displayed as error bars. Primer assay 
IDs were: MT1-MMP, Hs00237119_m1; 1 Integrin, Hs00559595_m1; 
3 Integrin, Hs01001469_m1; RAB5A, Hs00991290_m1; RAB5B, 
Hs00161184_m1; RAB5C, Hs00428044_m1; RAB4A, Hs00190157_
m1; RAB4B, Hs00535053_m1; RAB7A, Hs01115139_m1; RAB7B, 
Hs00332830_m1; RAB8A, Hs00180479_m1; RAB8B, Hs00213008_
m1; RABENOSIN-5 (ZFYVE20), Hs00223482_m1; and RABAPTIN-5, 
Hs01091595_m1.
siRNA experiments
The following siRNAs were used for knocking down specific genes. Sim-
ilar results were obtained regardless of the siRNA used. All sequences 
are 5 to 3. CLATHRIN, (1) TCCAATTCGAAGACCAATT; CLATHRIN, 
(2) CCTGCGGTCTGGAGTCAAC; ARF6 (1), AGCTGCACCGCAT-
TATCAAT; ARF6 (2), and CACCGCATTATCAATGACCGTT were from 
GE Healthcare. RAB5A (1), GCCAGAGGAAGAGGAGTAGACCTTA; 
RAB5A (2), GGAGAGTCCGCTGTTGGCAAATCAA; RAB5B (1), GCA-
GATGACAACAGCTTATTGTTCA; RAB5B (2), GCTATGAACGTGAA-
TGATCTCTTCC; RAB5C (1), TCCGCTTTGTCAAGGGACAGTTTCA; 
RAB5C (2), CAATGAACGTGAACGAAATCTTCAT; Integrin 1 (1), 
CCTAAGTCAGCAGTAGGAACATTAT; Integrin 1 (2), GGGAGC-
CACAGACATTTACATTAAA; Integrin 3 (1), CCTCCAGCTCATTGTT-
GATGCTTAT; Integrin 3 (2), GAGGCCACGTCTACCTTCACCAATA; 
RABENOSYN-5 (1), CCACTATGTTGTGGAAGTCAATAAA; RABEN-
OSYN-5 (2), GGTCTATTATGTGCAAGAAGTGTAT; RABAPTIN-5 (1), 
GTGTTCCAATTACGAAAAA; RABAPTIN-5 (2), CCAAAGCTTTAGGC-
TATAA; N-WASP(1), TCAAATTAGAGAGGGTGCTCAGCTA; N-WASP 
HGF-treated HeLa cells, 20% and 30% of the cells formed CDRs and 
invadosomes, respectively. In some experiments, the formation of CDRs 
and invadosomes was monitored by real-time microscopy. CDRs generally 
formed (on average 1–3/cell) within 5–8 min of HGF stimulation. Inva-
dosomes generally formed within 15–60 min of HGF stimulation.
In situ zymography
Labeling of gelatin with the Alexa Fluor 594 dye was performed using the 
Alexa Fluor 594 protein labeling kit (Invitrogen) according to the manufac-
turer’s instructions. Glass coverslips (20 mm in diameter) were coated with 
2 mg/ml Alexa Fluor 594–gelatin and cross-linked with 0.5% glutaralde-
hyde. Cells were plated onto matrix-coated coverslips and incubated at 
37°C to allow degradation, then fixed with 4% paraformaldehyde, washed 
in PBS, and stained with specific antibodies and FITC-phalloidin.
The extent of matrix degradation was calculated by determining a 
degradation index, which represents the total relative area of degradation 
with respect to total area of degradation in control samples normalized for 
the number of cells.
MT1-MMP recycling assay
HeLa cells transiently transfected with Cherry-MT1-MMP were plated on cov-
erslips, washed twice with PBS, and incubated at 16°C for 2 h in a serum-
free, CO2-independent, L-15 medium Leibovitz (Gibco) containing 10 µg/ml 
of mouse MT1-MMP antibody that recognizes the extracellular portion of the 
protease. Under these conditions, recycling is blocked, whereas internaliza-
tion proceeds, albeit at a reduced rate (Punnonen et al., 1998). The cells 
were washed with ice-cold PBS and incubated for 5 min at 4°C with mild 
acid wash buffer (150 mM NaCl, 1 mM CaCl2, and 20 mM acetic acid, 
pH 4.6), followed by successive rinses with PBS to remove surface antibody. 
The cells were then transferred to 37°C to allow recycling of internalized MT1-
MMP. At various time points, cells were fixed with 4% paraformaldehyde 
without permeabilization, then blocked in 1% BSA for 30 min followed by in-
cubation for 1 h with the anti–mouse Alexa Fluor 488–conjugated antibody. 
MT1-MMP surface expression was examined using the 63× (NA 1.4) lens of 
an inverted microscope (Leica) with constant gain and pinhole parameters. 
Relative cell surface expression was quantified for at least 30 cells per experi-
mental condition using ImageJ software after having defined manually the cell 
contour on confocal z sections. The total anti–MT1-MMP ab signal is the sum 
of cytoplasmic and cell surface signal. Recycled MT1-MMP is calculated as 
the fraction on the cell surface/total MT1-MMP at each time point.
In situ proximity ligation assay (PLA)
We detected the association in situ between MT1-MMP/Integrin 3 with a 
Duolink II detection kit (Olink Bioscience), according to the manufacturer’s 
instructions. Primary antibodies against overexpressed MT1-MMP and en-
dogenous Integrin 3 were incubated in the presence of blocking solution 
(PBS, 0.05 Tween 20, 1% BSA). This was followed by incubation with sec-
ondary antibodies conjugated to oligonucleotides that are ligated to form 
a closed circle in the presence of Duolink Ligation Solution (Söderberg 
et al., 2006). In the final step, we added DNA polymerase in order to am-
plify ligated oligos, which were detected using complementary, fluorescently 
labeled oligonucleotides.
In vitro 3D assays
3D cell migration. For 3D collagen gel invasion assays we used type I colla-
gen diluted in 1× DMEM, Hepes (50 mM), NaOH (5 mM), and NaHCO3 
(0.12%), at a final concentration of 2.3 mg/ml in the presence of 100 ng/ml 
HGF. We then casted unpolymerized collagen in home-made migration 
chambers (0.4 mm thick) at 37°C for 1 h. Cells were added on top of col-
lagen gel. Chambers were sealed with dental glue and incubated at 37°C, 
5% CO2. Time-lapse recording was performed using an inverted micro-
scope (Eclipse TE2000-E; Nikon).
3D morphological analysis of cells embedded in Matrigel. HeLa cells were 
embedded in Matrigel. To this end, 2 × 105 cells/ml were suspended with 
Matrigel solution (21 mg/ml) to achieve a final concentration of 7 mg/ml 
at 4°C. 300 µl of this cell suspension was seeded in an 8-well chamber 
slide (Lab-Tek) and allowed to solidify at 37°C for 4 h. Cells were fixed in 
4% paraformaldehyde and stained with anti-RAB5 Ab and phalloidin to 
detect F-actin. Sequential z sections (at least 30) of embedded cells were 
obtained by indirect immunofluorescence microscopy using a confocal 
microscope (TCS SP2 AOBS; Leica).
Organotypic matrix invasion assay
U937 cells (2.5 × 104) were embedded in rat-tail type I collagen (final 
concentration of 4 mg/ml). After 3 d of incubation at 37°C, gels were 
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(2), CCCTCTTCACTTTCCTCGGCAAGAA; MT1-MMP (1), CCTACGAGA-
GGAAGGATGGCAAATT; MT1-MMP (2), CCGACAAGATTGATGCTG-
CTCTCTT; RAB7A (1), CAGGAAACGGAGGTGGAGCTGTACA; RAB7A 
(2), CCCTAGATAGCTGGAGAGATGAGTT; RAB7B (1), TGACATCAAT-
GTGGTGCAAGCGTTT; RAB7B (2), GCCAGCATCCTCTCCAAGATTATCA; 
RAB8A (1), GCAAGAGAATTAAACTGCAGATATG; RAB8A (2), GCGAA-
GACCTACGATTACCTGTTCA; RAB8B (1), GAGAAGCTAGCAATTG-
ACTATGGGA; RAB8B (2), CCTGGGTAACAAATGTGATATGAAT; RAB4A 
(1), GGAGTGGAATTTGGTTCAAAGATAA; RAB4A (2), GAGAAACC-
TACAATGCGCTTACTAA; RAB4B (1), CCCAGGAGAATGAGCTGAT-
GTTCCT; and RAB4B (2), AGAGGATGGGCTCTGGCATTCAGTA were 
from Life Technologies.
For all siRNA experiments, the appropriate scrambled oligos were 
used as control siRNAs (ctr-siRNA).
Orthotopic xenograft in vivo studies
All animal experiments were performed in accordance with national and 
international laws and policies. Mice were bred and housed under patho-
gen-free conditions in our animal facilities at Cogentech Consortium at the 
FIRC Institute of Molecular Oncology Foundation and at the European Insti-
tute of Oncology in Milan.
Subcutaneous tumor development in (NSG) NU/NU nude mice Crl:
NU-Foxn1nu. Before injection, control or RAB5A-expressing HeLa cells 
were trypsin detached, washed twice, and resuspended in PBS at a 
final concentration of 1 × 106 cells/13 µl. The cell suspension was then 
mixed with 5 µl of growth factor–reduced Matrigel and 2 µl Trypan 
blue solution, and maintained on ice until injection. To establish tumors 
in mice, cells were injected subcutaneously in the mid-dorsal region of 
female nude mice, 6–9 wk old. Tumors were allowed to grow for 4 wk. 
Tumor growth was monitored weekly using digital calipers, and tumor 
volume was calculated according to the formula: L × W2/2 = mm3. 
The tumors were excised, fixed in 4% phosphate-buffered formalin, and 
embedded in paraffin. 5-µm sections of the entire tumor samples were 
prepared and slides were counterstained with H&E and with anti-RAB5 
antibody for the detection of metastases. The Scan Scope XT device and 
the Aperio Digital pathology system software (Aperio; Leica) were used 
to detect metastases.
Subcutaneous tumor development in NOD SCID gamma mice. Control 
and RAB5AS34N-MCF10.DCIS.com (100,000 cells) were injected subcu-
taneously into 6–9-wk-old female NOD.Cg-PrkdcscidIl2rgtm1Wjl/SzJ (com-
monly known as the NOD SCID gamma; NSG) mice in 50% Matrigel (BD) 
as described previously (Hu et al., 2008). Tumors were allowed to grow 
for 4 d before feeding the animals with doxycycline. 1–3 wk later, xeno-
grafts were measured and then snap frozen on dry ice and stored at 
80°C for protein or mRNA analysis, or formalin fixed and paraffin em-
bedded for IHC staining.
Mammary fat pad tumor development in NSG mice. Before injection, con-
trol HeLa, RAB5A-HeLa, control-MDA-MB-231, and RAB5AS34N-MDA-MB-
231 cells were trypsin detached, washed twice, and resuspended in PBS to 
a final concentration of 5 × 106 cells/13 µl. The cell suspension was then 
mixed with 5 µl growth factor–reduced Matrigel and 2 µl Trypan blue solu-
tion and maintained on ice until injection. Aseptic conditions under a laminar 
flow hood were used throughout the surgical procedure. Female NSG mice, 
6–9 wk old, were anesthetized with 375 mg/Kg Avertin, laid on their 
backs, and injected with a 20-µl cell suspension directly in the fourth mam-
mary fad pad. In the case of control and RAB5AS34N-MDA-MB-231, mice 
were fed with doxycycline after 3 wk. Tumor growth was monitored weekly 
using digital calipers, and tumor volume was calculated according to 
the formula: L × W2/2 = mm3. After 4–6 wk, mice were anesthetized with 
375 mg/Kg Avertin to remove primary tumors (mastectomy). The tumor mass 
was carefully removed and the incision closed with wound clips. Tumor metas-
tasis was analyzed after an additional 4 wk. To this end, mice were sacrificed, 
and ipsilaterally disseminated tumors and lung tissue were removed. For histo-
logical evaluation, primary tumors and metastases in lung tissues were fixed in 
4% phosphate-buffered formalin and embedded in paraffin. 3-µm sections of 
the entire lungs were made, and slides were counterstained with H&E and with 
anti-GFP antibody for the detection of metastases. The Scan Scope XT de-
vice and the Aperio Digital pathology system software (Aperio) were used 
to detect metastases.
Short-term lung colonization assay. 5 × 105 control MDA-MB231 cells 
(labeled with E-Fluor 670) and 5 × 105 siRNA RAB5A/B/C MDA-MB231 
cells (labeled with CFSE) were mixed in 200 µl PBS and injected intrave-
nously. Mice were then sacrificed after 2, 24, and 96 h. The lungs were 
removed and micrometastases were visualized using a fluorescence micro-
scope and counted.
Intravital microscopy. We induced anesthesia with a high dose of 
isoflurane 4%, verified nonresponsiveness, and then performed the surgery 
under a lower dose of anesthetic (2.5%). Imaging was performed with a 
2% dose of anesthetic. Anesthesia at this level maintains the mouse in a 
nonresponsive state, but permits a nonforced respiratory pattern. A trained 
operator was present during imaging to enable prompt intervention if the 
animal were to become responsive during this time.
Image acquisition
Confocal microscopy was performed on a Leica TCS SP2 AOBS confocal 
microscope controlled by Leica Confocal Software and equipped with vio-
let (405 nm laser diode), blue (argon, 488 nm), yellow (561 nm Solid State 
Laser), and red (633 nm HeNe Laser) excitation laser lines. A 63× oil-
immersion objective lens (HCX Plan-Apochromat 63× NA 1.4 Lbd Bl; Leica) 
was used for analysis. Image acquisition conditions were set to remove 
channel crosstalk, optimizing spectral detection bands and scanning modali-
ties. ImageJ software was used for data analysis.
Time-lapse imaging of cell migration was performed on an inverted 
microscope (Eclipse TE2000-E; Nikon) equipped with an incubation cham-
ber (OKOLab) maintained at 37°C in an atmosphere of 5% CO2. Movies 
were acquired with a Cascade II 512 (Photometrics) charge-coupled de-
vice (CCD) camera controlled by MetaMorph Software (Universal Imag-
ing) using a 10× magnification objective lens (Plan Fluor 10×, NA 0.30). 
Tracking of cells was performed using the “Manual Tracking” and “Chemo-
taxis and migration tool” plug-in distributed by ImageJ software.
Total internal reflection fluorescence (TIRF) imaging of cells was per-
formed with a TIRF workstation (Biosystem; Olympus) based on MetaMorph 
Software (Universal Imaging) and equipped with an incubation chamber 
(OKOLab) maintained at 37°C in an atmosphere of 5% CO2. For excita-
tion of Alexa Fluor 405, Alexa Fluor 488, and Texas red, a 405-nm laser 
diode, a 491-nm Ar laser, and a 561-nm Kr laser were used, respectively, 
coupled to an inverted epifluorescence motorized microscope (IX81; Olym-
pus). Cells plated on glass coverslips were viewed through a high-aperture 
60× objective lens (UIS2 60× TIRFM Plan-Apochromat N, NA 1.45; Olym-
pus) with an additional 1.6× magnification lens. Images (12-bit depth) 
were acquired using an Orca-ER Cooled CCD digital camera (Hamamatsu 
Photonics).
Intravital microscopy was performed with a confocal microscope 
(Leica; TCS SP5) on an upright microscope (DM6000 CFS) equipped with 
blue (argon, 488 nm), yellow (561 nm solid state laser), and red (633 nm 
solid state laser) excitation laser lines with an 20× water immersion objec-
tive lens (HCX Apochromat L 20× NA 1; Leica) and controlled by Leica 
LAS AF software (Leica). We used a two-photon excitation (2PE) technique 
with a pulsed infrared laser (Chameleon Ultra II; Coherent) at 980 nm. 
3D reconstructions of primary tumors were done using Volocity software 
(PerkinElmer).
Live cell DeltaVision imaging was performed using a DeltaVision 
Elite imaging system (Applied Precision) controlled by softWoRx Explorer 
2.0 (Applied Precision) equipped with a CCD camera (CoolSNAP HQ2; 
Photometrics) and an inverted microscope (IX71; Olympus) using a 100× 
oil-immersion objective lens (UPLS Apochromat 100× NA 1.4; Olympus). 
The system was equipped with an environmental chamber (Applied Preci-
sion) maintained at 37°C in an atmosphere of 5% CO2. Images were ac-
quired for 1 min every 3 s as a single z plane.
Image analysis
For time-lapse imaging of cell migration, the tracking of cells was per-
formed using the “Manual tracking” and “Chemotaxis and migration 
tool” plug-in distributed by ImageJ software. Notably, the invasion index 
represents the efficiency of invasion of at least 20 cells along the axis 
parallel to the direction of invasion into the type I collagen gel. The inva-
sion index was calculated by dividing the net distance covered by a cell 
over the chemotactic invasion axis (Yc) by the total accumulated distance 
(Dc). Pearson’s coefficient was calculated using the JACoP plug-in with 
ImageJ software.
Quantification of motility events by intravital microscopy
Each video generated by intravital two-photon microscopy was analyzed 
for the following criteria, as described in Wyckoff et al. (2000): (1) cell pro-
trusions (both blebbing and pseudopodia extension were included among 
cell protrusions, although blebbing was a rare event under the conditions 
tested); and (2) cell locomotion (defined as a net cell displacement of a cell 
centroid over time). We monitored the appearance of the above migration 
features in a field of view of defined size (2.4 × 105 µm2) during 1 h of time 
lapse. The percentage of time-lapse sequences during which we recorded 
any of the events specified above was reported. Typically, we monitored 
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Figure S1.  RAB5A  expression  in  human 
breast  cancer and  the effects of RAB5AS34N 
on growth of primary  tumors  in  vitro and  in 
vivo. (A) Relative expression levels of RAB5A 
in different tumor cell lines. Vinculin was used 
as loading control. (B) Doxycycline-inducible 
RAB5AS34N-expressing and control MDA-
MB-231 cells were injected into the mam-
mary fat pads of NSG-null mice. 3 wk after 
injection, mice were fed with doxycyline to 
induce transgene expression. The growth of 
primary tumors was monitored weekly and tu-
mors were eventually removed after 4–6 wk. 
(B, left) Representative images of control (Ctr) 
or RAB5AS34N-MDA-MB-231 primary tumors 
grown for 4 wk in the mammary fat pads. 
(B, middle) Quantitation of the volume of con-
trol and RAB5AS34N-MDA-MB-231 tumors 
(n = 10 mice/group). (B, right) Expression of 
the transgene in the primary tumors was de-
tected by immunoblotting of total tumor lysates 
using the indicated antibodies. Vinculin was 
used as a loading control. (C) Doxycycline-in-
ducible RAB5AS34N-expressing and control 
MCF10.DCIS.com cells were injected subcu-
taneously into NSG-null mice as described in 
Fig. 2 D. 4 d after injection, mice were fed 
with doxycycline to induce transgene expres-
sion (Fig. 1 D). 1–3 wk later, tumor size was 
determined. The tumor volume was not sig-
nificantly different between the two groups 
(n = 10 mice/group). (D) Lysates from GFP-
LifeAct control or RAB5A-infected HeLa cells, 
induced with doxycycline for 48 h, were im-
munoblotted with the indicated antibodies 
(right) or processed for immunofluorescence as 
indicated (left). (E) GFP-LifeAct control (Ctr) or 
GFP-LifeAct-RAB5A–overexpressing (RAB5A) 
HeLa cells were injected into the mammary fat 
pads of NSG mouse as described in Fig. 3 A. 
Representative images of FFPE sections of con-
trol and RAB5-HeLa tumors stained with H&E 
(top left) or anti-GFP (top right). Quantitation 
of primary tumor size (weight, bottom left), 
apoptosis (number of caspase-3–positive cells, 
bottom middle), and proliferation (number of 
Ki67-positive cells, bottom right) expressed as 
mean ± SEM (error bars) of three independent 
experiments, where n = 5 mice/condition/ex-
periment. (F) GFP-LifeAct control (Ctr) or GFP-
LifeAct-RAB5A–overexpressing (RAB5A) HeLa 
cells were grown for 21 d on an organotypic 
collagen matrix culture, preconditioned with 
U937 macrophages. Representative multi-
photon-based SHG images of type I collagen 
fibers of cell-invaded organotypic matrices are shown. (G) Control (Ctr) or RAB5A-overexpressing (RAB5A) HeLa cells were injected subcutaneously into 
nude mice. After 4 wk, tumors were excised, measured, fixed, and processed for histological analysis. FFPE tumor tissue sections were stained with H&E or 
with anti-RAB5 antibody and hematoxylin. Stromal areas of primary tumors were analyzed by multiphoton-based SHG at different magnifications to detect 
interstitial collagen fiber organization. Enlarged views of the boxed areas on the left are shown on the right. (H) Histological sections of control (Ctr) or 
RAB5A-overexpressing (RAB5A) HeLa tumor cells obtained as described in D were stained with Picrosirius red and analyzed by multiphoton-based SHG 
to visualize collagen fiber organization of the stromal tissues surrounding the tumors. Bars: (B) 1 cm; (D) 10 µm; (E) 2.5 mm; (F) 100 µm; (G, H&E panels) 




matrix  and  for  invadosomes  formation. (A) 
Invasion into a native type I collagen matrix 
requires protease activity. An equal number of 
HT1080 cells, treated with the broad-spectrum 
metalloprotease inhibitor GM6001 or control 
vehicle, were placed on one side of a chamber 
slide in which 2.3 mg/ml of acid extracted–
only type I collagen gel containing 100 ng/ml 
HGF and 100 ng/ml EGF was polymerized. 
Migration tracks of randomly picked individual 
cells invading toward the HGF/EGF gradient 
over 18 h are shown (left, see also Video 4). 
Quantification of cell invasion expressed 
as the mean forward invasion index ± SEM 
(error bars) is shown (right). The analysis was 
conducted on at least 30 cells/experimental 
conditions in four independent invasion as-
says. *, P < 0.01. (B) RAB5A is sufficient to 
promote HeLa cell invasion. An equal number 
of HeLa cells transfected with pEGFP alone, or 
in combination with RAB5A, were treated with 
GM6001 and assessed for invasion ability as 
described in A. Migration tracks of randomly 
picked individual cells toward an HGF gradient 
over 18 h are shown (left, see also Video 6). 
The signal of GFP-positive cells at 18 h was 
detected by epifluorescence (right). Broken 
lines mark the upper interface between cell 
media and type I collagen gels. Bar, 200 µm. 
Quantification of cell invasion efficiency ex-
pressed as the mean forward invasion index 
± SEM (error bars) is shown (right). The analy-
sis was conducted on 45 single cells/experi-
ment in three independent invasion assays. *, 
P < 0.01. (C) An equal number of scrambled 
control (Ctr) or RAB5A,B,C-depleted (siRNA 
RAB5) MDA-MB-231 cells were assessed for 
their invasive ability in acid extracted–only 
polymerized type I collagen gel. Examples of 
migration tracks of randomly picked individual 
cells toward an HGF gradient over 48 h are 
shown (left; see also Video 9). Quantification 
of cell invasion expressed as mean forward in-
vasion index ± SEM (error bars) is also shown 
(middle). The analysis was conducted on 80 
single cells/experiment in four independent 
invasion assays. **, P < 0.005. Efficacy of 
RAB5 gene silencing was assessed by quan-
titative PCR (right). **, P < 0.005. (D–F) Si-
lencing of RAB5 genes impairs formation of 
HGF-induced invadosomes in various breast 
cancer lines. HGF-treated scrambled control 
(HGF) or RAB5A,B,C-depleted (siRNA RAB5) 
MDA-MB-231 (D), BT20 (E), and SUM149 (F) cells were plated onto fluorescently conjugated gelatin, stimulated with HGF (100 ng/ml) for 3 h, and stained 
with phalloidin. (D–F, left) Representative merged images of cells stained with phalloidin or processed for epifluorescence to reveal F-actin and fluorescently 
conjugated gelatin, respectively. Bar, 20 µm. (D–F, right) Quantification of gelatin degradation was performed as described in Materials and methods and 
is expressed as a degradation index. Data are the mean ± SEM (error bars; n = 100 cells/experiment in three independent ones). *, P < 0.01; **, P < 
0.005. Silencing of RAB5 genes was verified by quantitative PCR (bottom right). **, P < 0.005. (G) Doxycycline-inducible RAB5A-expressing and control 
(Ctr) MCF10.DCIS.com cells were plated as above to detect the focal area of gelatin degradation. (G, left) Representative merged images of cells stained 
with phalloidin or processed for epifluorescence to reveal F-actin and fluorescently conjugated gelatin, respectively. Bar, 20 µm. (G, middle) Relative area 
of degradation with respect to the area of degradation in control samples. Data are the mean ± SEM (error bars) of three independent experiments, where 
n = 120 cells/experiment. *, P < 0.01; **, P < 0.005. Elevation of RAB5A induced by doxycycline was verified by immunoblotting (right).
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Figure S3.  RAB5A is necessary and sufficient to promote N-WASP–dependent invadosome formation. (A) Control (HGF), RAB5A/B/C-silenced (siRNA 
RAB5), or RAB5S34N-expressing HeLa cells were plated onto fluorescently conjugated gelatin and stimulated with HGF (100 ng/ml) for 1 h, or left in serum 
free (SF) conditions. Cells were stained with phalloidin or anti-RAB5A Ab (RAB5AS34N). (A, top) Representative merged images of phalloidin labeling 
(green) and fluorescently conjugated gelatin (red). Arrows indicate examples of matrix-degrading invadosomes. Insets show magnifications of boxed re-
gions. RAB5AS34N-expressing cells were visualized by anti-RAB5A labeling and indicated with an asterisk (far right). Bar, 10 µm. (A, bottom) Quantifica-
tion of gelatin degradation was performed as described in Materials and methods and is expressed as the mean degradation index ± SEM (error bars) of 
at least three independent experiments, where n = 50 cells/experiment. Silencing of RAB5 genes was verified by quantitative PCR (bottom right). **, P < 
0.005. (B) HeLa cells were serum starved and mock treated (SF) or stimulated with HGF (100 ng/ml) for the indicated times. Total cell lysates were incu-
bated with GST-EEA1 to trap GTP-loaded RAB5A as described previously (Palamidessi et al., 2013). Lysate (top) and GST-EEA1 bound proteins (bottom, 
RAB-GTP) were revealed by immunoblotting with anti-RAB5 antibody. (C) Table reporting the localization of the indicated proteins within RAB5A-induced 
invadosomes in HeLa cells. (D) HeLa cells were transiently transfected with RAB5A and either control scrambled (Ctr) or one of two N-WASP siRNAs (siRNA 
N-WASP), and stained as indicated. Representative images of stained cells are shown. Arrows indicate ventral invadosomes. A magnification of boxed re-
gion is shown on the right. Bars: (left panels) 20 µm; (enlarged panel on the right) 1 µm. (E) Silencing of N-WASP was verified by immunoblotting of lysates 
of control (siRNA-scrambled) and N-WASP siRNA-treated (siRNA-1/2-N-WASP) cells (left). Quantification of the percentage of HeLa cells forming inva-
dosomes shown (right). Data are the mean ± SEM (error bars) of four independent experiments, where n = 100 cells/experiment. **, P < 0.005.
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Figure S4.  The RAB4–RABENOSYN-5 recycling pathway is necessary for HGF-induced invadosome formation. (A) Serum-starved HeLa cells were trans-
fected with scrambled siRNA (Ctr), siRNAs against RABENOSYN-5 (siRNA RBNS-5) or RAB4A and -B (siRNA RAB4), or with dominant-negative RAB4A-
S22N or GFP-RAB11S22N mutants. Transfected cells were plated onto fluorescently conjugated gelatin and stimulated with HGF for 3 h, or left in serum 
free conditions (SF). Cells were stained with phalloidin, anti-RAB4 (RAB4AS22N), or processed for epifluorescence to detect fluorescently labeled protein 
(GFP-RAB11S22N). Representative merged images of fluorescently conjugated gelatin (red), phalloidin labeling (green), anti-RAB4, and GFP-RAB11S22N 
labeling (bottom) are shown. Arrows indicate examples of invadosomes. Insets are magnifications of boxed regions. Bars, 20 µm. (B) Quantification of gel-
atin degradation is expressed as a degradation index (relative area of degradation with respect to the area of degradation in HGF-stimulated control sam-
ples). Data are presented as the mean degradation index ± SEM (error bars) of four independent experiments, where n = 60 cells/experiment. **, P < 
0.005. Silencing of RAB4A, RAB4B (set #1 and #2), and RABENOSYN-5 genes was performed using two independent siRNA oligos, which gave identical 
results, and was verified by quantitative PCR (right). **, P < 0.005. (C) Serum-starved MDA-MB-231 cells were transfected with scrambled siRNA (Ctr), si-
RNAs against RAB4A and -B (siRNA RAB4), plated onto fluorescently conjugated gelatin, and stimulated with HGF for 3 h, or left in serum-free conditions 
(SF). Representative merged images of fluorescently conjugated gelatin (red) and phalloidin labeling (green) are shown. Arrows indicate examples of inva-
dosomes. Bar, 20 µm. (D) Gelatin degradation was quantified as in B. Data are the mean degradation index ± SEM (error bars) of four independent experi-
ments, where n = 90 cells/experiment. **, P < 0.005. Silencing of RAB4A and RAB4B genes was performed using two sets (#1 and #2) of independent 
siRNA oligos, which gave identical results, and was verified by quantitative PCR (right). **, P < 0.005.
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Figure S5.  MT1-MMP colocalizes with RAB5A and RAB4A endosomes and  is required for HGF- and RAB5A-induced  invadosomes. (A) Serum-starved 
HeLa cells, transfected with either scrambled (Ctr) or anti–MT1-MMP siRNAs, were plated onto fluorescently conjugated gelatin and stimulated with HGF 
for 3 h, or left in serum free conditions (SF). Cells were stained with phalloidin. Representative merged images of fluorescently conjugated gelatin (red) 
and phalloidin labeling (green) are shown. Insets are magnifications of boxed regions. Arrows indicate examples of invadosomes. Identical results were 
obtained with a second anti–MT1-MMP siRNA (siRNA-MT1(2)). (B) Quantification of relative gelatin degradation (degradation index) and the relative num-
ber of invadosomes/cell (invadosome index) with respect to control HGF-stimulated cells (left and middle). Data are the mean ± SEM (error bars) of three 
independent experiments, where n = 30 cells/experiment. MT1-MMP silencing was verified by quantitative PCR. **, P < 0.005. (C) Unstimulated HeLa 
cells simultaneously expressing CFP-RAB5, Cherry-MT1-MMP, and GFP-RAB4A (top) or GFP–RABENOSYN-5 (bottom) were processed for epifluorescence 
to detect fluorescently labeled proteins, or stained with anti-EEA1 to detect the early endosomes. Representative confocal images are shown. (D) MT1-MMP 
localizes into early endosomes in cells embedded in a 3D matrix. CFP-RAB5–, GFP-RAB4–, and Cherry-MT1-MMP–expressing HeLa cells were embedded 
into 3D Matrigel, and their 3D morphology was analyzed by spinning disc microscopy. Bar, 20 µm. Images are representative of >50 analyzed cells. 
(E) Endogenous MT1-MMP localizes into RAB4A-, RABENOSYN-5–, and EEA1-positive early endosomes and only partially into LAMP1 late endosome in 
MCF10.DCIS.com. Growing MCF10.DCIS.com cells were transfected with GFP-RAB4A or GFP-RAB11; mock treated, fixed, and processed for epifluo-
rescence to detect fluorescently labeled proteins; or stained with the indicated antibody. Representative confocal images are shown. Pearson correlation 
coefficient (PCC) is shown on the right. (F) Stills from a time lapse of HGF-stimulated MCF10.DCIS.com cotransfected with RFP-Lifeact and either GFP-RAB5A 
or GFP-RAB4A. Consecutive time frames from Video 7 obtained by focusing on the plasma membrane confocal plane are shown. White arrowheads 
indicate vesicles that contact F-actin–rich PM invadosomes. Yellow arrowheads indicate a tubular structures manating from a  RAB4-positive endosome 
and contacting an F-actin–rich invadosome. Bars: (A) 20 µm; (C) 40 µm; (D) 20 µm; (E) 20 µm; (F) 5 µm.
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Table S1. Membrane trafficking molecules involved in the formation of migratory and invasive protrusions
Cellular processes Functional interference Circular dorsal ruffles Invadosomes
Endocytosis Ctr HeLa 1.0 1.0
CLATHRIN (RNAi) 0.19 ± 0.04b 0.32 ± 0.11a
DYNAMIN (DN) 0.02 ± 0.02b 0.18 ± 0.01a
16oC 0.13 ± 0.05b 0.11 ± 0.07b
Trafficking RAB5 (DN, RNAi) 0.04 ± 0.04b 0.02 ± 0.03b
RAB4 (DN, RNAi) 0.85 ± 0.16 0.23 ± 0.11a
RABENOSYN-5 (RNAi) 0.93 ± 0.12 0.03 ± 0.02b
ARF6 (DN, RNAi) 0.03 ± 0.02b 0.05 ± 0.04b
RAB35 (DN) 0.08 ± 0.05b 0.02 ± 0.03b
RAB11 (DN, RNAi) 0.80 ± 0.15 0.87 ± 0.19
RAB8 (RNAi) 1.02 ± 0.04 0.98 ± 0.09
RAB7 (RNAi) 1.04 ± 0.1 0.91 ± 0.12
A candidate siRNA-based or dominant negative (DN) screening was performed to identify endocytic molecules specifically required for the formation of HGF-
induced circular dorsal ruffles (CDRs) or invadosomes. HeLa cells were transfected with scrambled control (Ctr) or the indicated specific siRNA or dominant-nega-
tive isoform, and stimulated with HGF (100 ng/ml) for 10 min before fixing and staining with phalloidin. A shift-down in temperature to 16ºC was used to arrest 
recycling. The identification of F-actin–positive apical CDRs and ventral invadosomes was facilitated by 3D reconstruction of confocal serial z sections as shown in 
Video 10. The fraction of siRNA-treated HeLa cells forming CDR or invadosome structures relative to that of control, HGF-stimulated cells was calculated. Data are 




Tissue type Normal tissue Tumor tissue Normal tissue Tumor tissue P (2) Normal tissue Tumor Tissue P (t test)
Nr. analyzed Nr. analyzed RAB4A high  
(n and %)
RAB4A high  
(n and %)
Mean intensity Mean intensity
Breast 30 24 1 (3.33%) 20 (83.33%) <0.0001 0.20 1.13 <0.0001
Lung 22 25 7 (31.82%) 14 (56%) 0.0961 0.39 0.80 0.0029
Bladder 12 22 8 (66.67%) 15 (68.18%) 0.9281 0.83 0.93 0.5089
Colon 22 27 18 (81.82%) 27 (100%) 0.0208 0.93 1.48 <0.0001
Melanocytes vs. mela-
noma
13 18 0 (0%) 18 (100%) <0.0001 0.04 1.61 <0.0001
Kidney 14 19 13 (92.86%) 8 (42.11%) 0.0027 1.18 0.76 0.0211
Larynx 14 27 1 (7.14%) 5 (18.52%) 0.3038 0.29 0.43 0.2389
Prostate 19 18 19 (100%) 17 (94.44%) 0.2253 1.53 1.39 0.3379
Stomach 21 25 21 (100%) 16 (64%) 0.0022 1.69 0.90 <0.0001
Thyroid 17 20 6 (35.29%) 16 (80%) 0.005 0.68 0.93 0.0456
The number of normal and tumor samples analyzed (Nr. analyzed) and the number and percentage of RAB4A high-expressing (IHC score ≥1) samples are given for 
each screened tissue. Dysregulation (up- or down-regulation) was evaluated by assessing differences between the tumor and the normal groups with the Pearson 2 
test (RAB4A-high vs. RAB4A-low expressing samples, IHC score ≥1 vs. <1) and the Student’s t test. Mean protein expression was calculated and reported separately 
for tumor and normal tissues. Differences were judged as significant at confidence levels equal to or greater than 95% (P < 0.05). Analyses were performed using 
JMP statistical software (SAS Institute, Inc.). In tumor tissues, in all cases, the IHC signals of the over- or under-expressed protein were associated with the tumor cell 
component and not with the adjacent or infiltrating stroma. The same was true for normal tissues. Bold text indicates a significant difference.
Video 1.  A single plane of EGFP-LifeAct–positive RAB5A-HeLa tumors, where cells are seen either extending an actin-dense 
circular ruffles (arrowhead) and blebs (arrows). None of these events could be observed in control EGFP-HeLa tumors. The clip 
was obtained by intravital imaging (TCS SP5 upright DM600 CFS; Leica) as described in the Materials and methods section. 
Images were taken every 2 min for 54 min.
Video 2.  Areas  of  EGFP-LifeAct–positive  control  and  RAB5A-HeLa  tumors. Each clip obtained by intravital imaging with 
multiphoton microscopy (TCS SP5 upright DM600 CFS; Leica) lasts 22 min, with images taken every 2 min. The control video 
contains nonmotile cells. The RAB5A show rapidly moving cells from the center (arrowheads) to the right bottom side (related 
to Fig. 3 E).
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Video 3.   High-magnification time lapse of cells moving into 3D collagen in metalloprotease-dependent manner. (Top) Time-
lapse wide-field microscopy (Eclipse TE2000-E; Nikon) of HT1080 cells, treated with control vehicle or broad-spectrum metal-
loprotease inhibitor GM6001, invading into native type I collagen chamber slides (see also Fig. S2 A). (Bottom) Time-lapse 
wide-field microscopy (Eclipse TE2000-E; Nikon) of HeLa cells transfected with pEGFP alone or in combination with RAB5A, 
treated with control vehicle or GM6001 and tested for invasion into native type I collagen gel chamber slides (see also Fig. S2 B). 
Images were taken every 5 min for 13 h. Representative videos of at least six independent experiments are shown.
Video 4.  High-magnification time lapse (IX81 microscope; Olympus) of control (left) and RAB5A-expressing HeLa (right) cells 
moving into 3D collagen. HeLA cells embedded into 2.3 mg/ml acid extracted–only polymerized type I collagen gel. The gel 
was overlaid with medium containing 100 ng/ml HGF. Images were taken with a 63× objective lens every 20 s for 20 min. 
Control cells are round and immobile, whereas RAB5-expressing HeLA adopt a typical mesenchymal mode of motility. A repre-
sentative video of at least four independent experiments is shown. Please note the morphological and migratory changes that 
occur upon expression of RAB5A. This type of analysis, however, does not allow a precise quantitative evaluation of invasion 
parameters.
Video 5.   RAB5A is  required  for  invasion  into 3D collagen of various cancer cells. (Top) Time-lapse wide-field microscopy 
(Eclipse TE2000-E; Nikon) of control and doxycycline-inducible RAB5AS34N-MDA-MB-231 cells tested for invasion into native 
type I collagen gel chamber slides (see also Fig. 4 C). (Middle) Time-lapse wide-field microscopy (Eclipse TE2000-E; Nikon) 
of control and doxycycline-inducible RAB5AS34N-MCF10.DCIS.com cells tested for invasion into native type I collagen gel 
chamber slides (see also Fig. 4 D). (Bottom) Time-lapse wide-field microscopy (Eclipse TE2000-E; Nikon) of MDA-MB-231 
cells transfected with scrambled (Ctr) or anti-RAB5A/B/C siRNAs. Cells were placed on one side of a chamber slide in which 
2.3 mg/ml acid extracted–only polymerized type I collagen gel containing 100 ng/ml HGF was added (see also Fig. S2 C). 
Images were taken every 5 min for 48 h. Representative videos of at least four independent experiments are shown.
Video 6.  TIRF time-lapse microscopy (IX81; Olympus) of serum-free (SF) HeLa cells transfected with RFP-LifeAct and Fluores-
cein-MT1-MMP in the presence (bottom) or absence of RAB5A. RAB5A-expressing cells were stimulated with HGF. Videos are 
representative of at least three independent experiments. Images were taken every 2 s for 5 min. Only representative videos of 
control and RAB5A-expressing cells stimulated with HGF are shown. Similar results, however, were obtained with either HGF 
stimulation or RAB5 expression alone, although the concomitant treatment increases the number of cell forming invadosomes as 
well as degradation activities (not depicted).
Video 7.  DeltaVision time-lapse microscopy (IX71; Olympus) of HGF-stimulated Hela cells cotransfected with RFP-LifeAct and 
either GFP-RAB5A or GFP-RAB4A. The boxed region was magnified to visualize the motility of endosomal vesicles (see Fig. S5 F). 
Images were taken every 3 s for 1 min. Videos are representative of >50 cells from of at least three independent experiments.
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Video 8.  TIRF time-lapse microscopy (IX81, Olympus) of serum-free (SF) HeLa cells transfected with RFP-LifeAct and GFP–3 
integrin in the presence (bottom) or absence of RAB5A. RAB5A-expressing cells were stimulated with HGF. Images were taken 
every 2 s for 3 min. Videos are representative of at least three independent experiments (see also Fig. 8 B). Only representative 
videos of control and RAB5A-expressing cells stimulated with HGF are shown. Similar results, however, were obtained with 
either HGF stimulation or RAB5 expression alone, although the concomitant treatment increases the number of cell forming 
invadosomes as well as degradation activities (not depicted).
Video 9.  Time-lapse wide field microscopy (Eclipse TE2000-E; Nikon) of RAB5A-expressing HeLa cells were treated with the 
indicated siRNAs. Cells were placed on one side of a chamber slide in which 2.3 mg/ml acid extracted–only polymerized type 
I collagen gel containing 100 ng/ml HGF was added (see also Fig. 9 A). Images were taken every 5 min for 33 h. Videos are 
representative of at least three independent experiments.
Video 10.   RAB4A and 3 integrin are required for invasion into 3D collagen of breast cancer cells. (Top) Time-lapse wide-
field microscopy (Eclipse TE2000-E; Nikon) of MDA-MB-231 cells transfected with scrambled (Ctr) or anti-RAB4A/B siRNAs. 
Cells were placed on one side of a chamber slide in which 2.3 mg/ml acid extracted–only polymerized type I collagen gel 
containing 100 ng/ml HGF was added (see also Fig. 9 B). (Bottom) Time-lapse wide-field microscopy of doxycycline-inducible 
RAB4AS22N-expressing and control MCF10.DCIS.com. Cells were placed on one side of a chamber slide in which 2.3 mg/ml 
acid extracted–only polymerized type I collagen gel containing 100 ng/ml HGF was added (see also Fig. 9 C). Images were 
taken every 5 min for 30 h. Representative videos of at least four independent experiments are shown.
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